{
  "metadata": {
    "version": "2.1.0",
    "created_date": "2026-01-25",
    "description": "Clinically accurate synthetic PA cases with embedded compensating factor patterns for AI pattern discovery",
    "total_cases": 350,
    "date_range": {
      "earliest_submission": "2023-01-01",
      "latest_submission": "2025-12-28"
    },
    "outcome_distribution": {
      "approved": 218,
      "denied": 82,
      "info_request": 50,
      "approval_rate": 0.623
    },
    "payer_breakdown": {
      "Cigna": {
        "total_cases": 162,
        "approval_rate": 0.63
      },
      "UnitedHealthcare": {
        "total_cases": 188,
        "approval_rate": 0.617
      }
    },
    "embedded_patterns": {
      "documentation_impact": {
        "therapeutic_drug_monitoring": {
          "with_tdm_approval_rate": 0.805,
          "without_tdm_approval_rate": 0.518,
          "impact": "+28.7% approval rate with TDM"
        },
        "fecal_calprotectin": {
          "with_fcp_approval_rate": 0.72,
          "without_fcp_approval_rate": 0.38,
          "impact": "+34.0% approval rate with fecal calprotectin"
        }
      },
      "payer_specific": {
        "Cigna": [
          "Requires fecal calprotectin for IBD cases (policy effective 2024-01-01)",
          "Strict on disease severity documentation",
          "Average decision time: 7 days for complete submissions"
        ],
        "UnitedHealthcare": [
          "Requires documented CDAI/HBI for Crohn's, Mayo for UC",
          "More lenient on fecal calprotectin",
          "Average decision time: 5 days for complete submissions"
        ]
      },
      "appeal_patterns": {
        "overall_appeal_rate": 0.512,
        "appeal_success_rate": 0.595,
        "insight": "Appeals within 7 days of denial with additional documentation have highest success rate"
      },
      "compensating_factors": {
        "severity_overrides_tb_screening": {
          "description": "High disease severity (CRP >15, fistula, CDAI >300) compensates for missing TB screening",
          "approval_rate_with_pattern": 0.78,
          "cases_count": 35
        },
        "attestation_overrides_step_therapy": {
          "description": "Physician severity attestation with documented urgency compensates for incomplete step therapy",
          "approval_rate_with_pattern": 0.82,
          "cases_count": 30
        },
        "endoscopy_overrides_fecal_calprotectin": {
          "description": "Recent endoscopy with documented active disease compensates for missing fecal calprotectin",
          "approval_rate_with_pattern": 0.75,
          "cases_count": 20
        },
        "lab_severity_bundle": {
          "description": "CRP >20 + albumin <3.0 + ESR >40 as severity bundle increases approval even with gaps",
          "approval_rate_with_pattern": 0.85,
          "cases_count": 28
        }
      }
    },
    "clinical_accuracy_notes": [
      "ICD-10 codes match official Crohn's (K50.x) and UC (K51.x) classifications",
      "Disease severity scores use validated instruments (CDAI, HBI, Mayo, UCEIS)",
      "Step therapy reflects real-world biologic sequencing requirements",
      "Lab values (CRP, fecal calprotectin, albumin) within clinically expected ranges",
      "Prior treatment durations reflect minimum therapeutic trial requirements",
      "Compensating factor patterns reflect real-world payer behavior where severe disease can override documentation gaps"
    ],
    "pattern_discovery_targets": {
      "primary_patterns": [
        "Missing TB screening + CRP>15 + severe classification \u2192 78% approval (vs 45% without severity)",
        "Incomplete step therapy + physician attestation + urgency docs \u2192 82% approval",
        "Missing fecal calprotectin + recent endoscopy showing active disease \u2192 75% approval",
        "Lab severity bundle (CRP>20, albumin<3.0, ESR>40) \u2192 85% approval regardless of other gaps"
      ],
      "actionable_insights": [
        "When TB screening is pending, emphasize disease severity markers to increase approval likelihood",
        "Physician attestation with urgency documentation can bypass standard step therapy requirements",
        "Recent endoscopy is a strong substitute for fecal calprotectin",
        "Multiple elevated inflammatory markers create a severity bundle that improves approval odds"
      ]
    }
  },
  "cases": [
    {
      "case_id": "HC-2023-0001",
      "patient_demographics": {
        "age": 20,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 310,
        "hbi_score": null,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 761,
        "crp": 29.4,
        "esr": 67,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "tb_screening",
        "fecal_calprotectin"
      ],
      "submission_date": "2023-01-01",
      "submission_day_of_week": "Sunday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0002",
      "patient_demographics": {
        "age": 56,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 433,
        "hbi_score": null,
        "ses_cd_score": 9,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 865,
        "crp": 22.7,
        "esr": 73,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 52,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2023-01-02",
      "submission_day_of_week": "Monday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0003",
      "patient_demographics": {
        "age": 58,
        "gender": "Female",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 417,
        "hbi_score": 16,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1283,
        "crp": 52.5,
        "esr": 84,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 392
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-01-12",
      "submission_day_of_week": "Thursday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Step therapy exception granted based on physician attestation of disease severity and clinical urgency. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0004",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 57.6,
        "esr": 55,
        "albumin": 4.0,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 12,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-01-13",
      "submission_day_of_week": "Friday",
      "submission_month": 1,
      "outcome": "denied",
      "days_to_decision": 12,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 10,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 24
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0005",
      "patient_demographics": {
        "age": 48,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 5.9,
        "esr": 37,
        "albumin": 3.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 7,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 4,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 3,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_180_days",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history",
        "fecal_calprotectin"
      ],
      "submission_date": "2023-01-14",
      "submission_day_of_week": "Saturday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2023-0006",
      "patient_demographics": {
        "age": 36,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 370,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1446,
        "crp": 34.3,
        "esr": 67,
        "albumin": 3.0,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-01-25",
      "submission_day_of_week": "Wednesday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0007",
      "patient_demographics": {
        "age": 19,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 542,
        "crp": 75.4,
        "esr": 70,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-01-25",
      "submission_day_of_week": "Wednesday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0008",
      "patient_demographics": {
        "age": 37,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 24.2,
        "esr": 64,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 5,
          "outcome": "intolerance"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 4,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2023-01-25",
      "submission_day_of_week": "Wednesday",
      "submission_month": 1,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0009",
      "patient_demographics": {
        "age": 40,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 344,
        "hbi_score": 15,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 592,
        "crp": 37.6,
        "esr": 50,
        "albumin": 4.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-01-26",
      "submission_day_of_week": "Thursday",
      "submission_month": 1,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0010",
      "patient_demographics": {
        "age": 23,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 594,
        "hbi_score": null,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 38.3,
        "esr": 34,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 299
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history",
        "tb_screening"
      ],
      "submission_date": "2023-01-30",
      "submission_day_of_week": "Monday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2023-0011",
      "patient_demographics": {
        "age": 34,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 397,
        "hbi_score": 11,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 715,
        "crp": 29.7,
        "esr": 26,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 13,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 15,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-02-01",
      "submission_day_of_week": "Wednesday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 22,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 28
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0012",
      "patient_demographics": {
        "age": 18,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 334,
        "hbi_score": 8,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 543,
        "crp": 33.6,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 16,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-02-05",
      "submission_day_of_week": "Sunday",
      "submission_month": 2,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Disease severity scores required",
        "Prior treatment documentation needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0013",
      "patient_demographics": {
        "age": 48,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 425,
        "hbi_score": 15,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 977,
        "crp": 40.9,
        "esr": 55,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2023-02-07",
      "submission_day_of_week": "Tuesday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0014",
      "patient_demographics": {
        "age": 19,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 599,
        "crp": 67.7,
        "esr": null,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-02-09",
      "submission_day_of_week": "Thursday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 18,
      "info_request_details": null,
      "denial_reason": "Dosing not consistent with guidelines",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 29,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 15
      },
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Denied: Dosing not consistent with guidelines"
    },
    {
      "case_id": "HC-2023-0015",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 590,
        "hbi_score": 17,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 54.0,
        "esr": null,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history"
      ],
      "submission_date": "2023-02-16",
      "submission_day_of_week": "Thursday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0016",
      "patient_demographics": {
        "age": 36,
        "gender": "Female",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 476,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 773,
        "crp": 62.6,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-02-17",
      "submission_day_of_week": "Friday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2023-0017",
      "patient_demographics": {
        "age": 45,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 382,
        "hbi_score": 16,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1453,
        "crp": 18.6,
        "esr": 47,
        "albumin": 3.5,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2023-02-23",
      "submission_day_of_week": "Thursday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0018",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 511,
        "hbi_score": 9,
        "ses_cd_score": 9,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 874,
        "crp": 13.6,
        "esr": null,
        "albumin": 3.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-02-25",
      "submission_day_of_week": "Saturday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Prior authorization form incomplete",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 21,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 16
      },
      "notes": "Complete documentation package submitted. Denied: Prior authorization form incomplete Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0019",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 312,
        "hbi_score": 13,
        "ses_cd_score": 12,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 36.9,
        "esr": null,
        "albumin": 3.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-02-25",
      "submission_day_of_week": "Saturday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 7,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 25
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0020",
      "patient_demographics": {
        "age": 58,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 298,
        "hbi_score": null,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 75.5,
        "esr": 47,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "partial_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 16,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_180_days",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history",
        "tb_screening",
        "fecal_calprotectin"
      ],
      "submission_date": "2023-02-27",
      "submission_day_of_week": "Monday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2023-0021",
      "patient_demographics": {
        "age": 43,
        "gender": "Female",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 391,
        "hbi_score": 15,
        "ses_cd_score": 12,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 982,
        "crp": 42.5,
        "esr": 33,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-02-27",
      "submission_day_of_week": "Monday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2023-0022",
      "patient_demographics": {
        "age": 20,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 519,
        "hbi_score": 11,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 32.1,
        "esr": 56,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report"
      ],
      "submission_date": "2023-03-02",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0023",
      "patient_demographics": {
        "age": 55,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 8.1,
        "esr": 45,
        "albumin": 3.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 10,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-03-05",
      "submission_day_of_week": "Sunday",
      "submission_month": 3,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0024",
      "patient_demographics": {
        "age": 23,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 755,
        "crp": 37.1,
        "esr": 58,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 51,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 5,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report",
        "fecal_calprotectin"
      ],
      "submission_date": "2023-03-08",
      "submission_day_of_week": "Wednesday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2023-0025",
      "patient_demographics": {
        "age": 19,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 512,
        "hbi_score": 14,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 929,
        "crp": 47.8,
        "esr": 84,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 15,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 26,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-03-09",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0026",
      "patient_demographics": {
        "age": 35,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 576,
        "hbi_score": 13,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 20.7,
        "esr": null,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 25,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 354
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2023-03-13",
      "submission_day_of_week": "Monday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0027",
      "patient_demographics": {
        "age": 18,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 508,
        "hbi_score": 15,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 6.6,
        "esr": null,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation"
      ],
      "documentation_missing": [
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "colonoscopy_report"
      ],
      "submission_date": "2023-03-14",
      "submission_day_of_week": "Tuesday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0028",
      "patient_demographics": {
        "age": 25,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1200,
        "crp": 62.8,
        "esr": 37,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2023-03-19",
      "submission_day_of_week": "Sunday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0029",
      "patient_demographics": {
        "age": 20,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 445,
        "hbi_score": 20,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 585,
        "crp": 77.4,
        "esr": null,
        "albumin": 2.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 7,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-03-24",
      "submission_day_of_week": "Friday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0030",
      "patient_demographics": {
        "age": 36,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1154,
        "crp": 22.5,
        "esr": 42,
        "albumin": 4.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 364
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-03-26",
      "submission_day_of_week": "Sunday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0031",
      "patient_demographics": {
        "age": 45,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 963,
        "crp": 70.7,
        "esr": null,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2023-03-30",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2023-0032",
      "patient_demographics": {
        "age": 53,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 507,
        "hbi_score": 8,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 54.2,
        "esr": 73,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-03-31",
      "submission_day_of_week": "Friday",
      "submission_month": 3,
      "outcome": "info_request",
      "days_to_decision": 6,
      "info_request_details": [
        "Disease severity scores required",
        "Fecal calprotectin test results needed",
        "Prior treatment documentation needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0033",
      "patient_demographics": {
        "age": 23,
        "gender": "Female",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 363,
        "hbi_score": 16,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 39.8,
        "esr": null,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 3,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2023-04-04",
      "submission_day_of_week": "Tuesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0034",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.913",
        "description": "Crohn's disease, unspecified, with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 444,
        "hbi_score": 9,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 456,
        "crp": 27.1,
        "esr": 21,
        "albumin": 3.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-04-04",
      "submission_day_of_week": "Tuesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2023-0035",
      "patient_demographics": {
        "age": 40,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 324,
        "hbi_score": 14,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 68.2,
        "esr": null,
        "albumin": 3.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2023-04-11",
      "submission_day_of_week": "Tuesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2023-0036",
      "patient_demographics": {
        "age": 39,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 425,
        "hbi_score": 19,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 724,
        "crp": 58.6,
        "esr": 47,
        "albumin": 3.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 326
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 311
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-04-15",
      "submission_day_of_week": "Saturday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0037",
      "patient_demographics": {
        "age": 25,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 155,
        "hbi_score": 8,
        "ses_cd_score": 25,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 5.5,
        "esr": null,
        "albumin": 3.6,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 3,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 21,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2023-04-17",
      "submission_day_of_week": "Monday",
      "submission_month": 4,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 17,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 15
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0038",
      "patient_demographics": {
        "age": 19,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 290,
        "hbi_score": null,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1167,
        "crp": 11.6,
        "esr": 40,
        "albumin": 2.7,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 13,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 101
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 14,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 340
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history",
        "fecal_calprotectin"
      ],
      "submission_date": "2023-04-22",
      "submission_day_of_week": "Saturday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2023-0039",
      "patient_demographics": {
        "age": 23,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 802,
        "crp": 50.5,
        "esr": 59,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 41,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 243
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-04-22",
      "submission_day_of_week": "Saturday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0040",
      "patient_demographics": {
        "age": 59,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 434,
        "hbi_score": 16,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 480,
        "crp": 20.7,
        "esr": 27,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2023-04-22",
      "submission_day_of_week": "Saturday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0041",
      "patient_demographics": {
        "age": 26,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1478,
        "crp": 56.9,
        "esr": 56,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2023-04-22",
      "submission_day_of_week": "Saturday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2023-0042",
      "patient_demographics": {
        "age": 58,
        "gender": "Male",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 583,
        "hbi_score": null,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 491,
        "crp": 62.9,
        "esr": null,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 16,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 382
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 52,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 113
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 214
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-04-23",
      "submission_day_of_week": "Sunday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0043",
      "patient_demographics": {
        "age": 20,
        "gender": "Female",
        "state": "GA"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 362,
        "hbi_score": 17,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 63.2,
        "esr": 62,
        "albumin": 3.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-04-26",
      "submission_day_of_week": "Wednesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0044",
      "patient_demographics": {
        "age": 53,
        "gender": "Female",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 583,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 323,
        "crp": 28.5,
        "esr": 84,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 37,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-04-28",
      "submission_day_of_week": "Friday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0045",
      "patient_demographics": {
        "age": 45,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 499,
        "hbi_score": null,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 956,
        "crp": 23.3,
        "esr": 80,
        "albumin": 4.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-04-28",
      "submission_day_of_week": "Friday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0046",
      "patient_demographics": {
        "age": 36,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 468,
        "hbi_score": 14,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1416,
        "crp": 23.5,
        "esr": 59,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 280
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 301
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-05-05",
      "submission_day_of_week": "Friday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0047",
      "patient_demographics": {
        "age": 24,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 743,
        "crp": 68.7,
        "esr": 65,
        "albumin": 2.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 45,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 299
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-05-05",
      "submission_day_of_week": "Friday",
      "submission_month": 5,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0048",
      "patient_demographics": {
        "age": 33,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 246,
        "hbi_score": 17,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1182,
        "crp": 42.8,
        "esr": 36,
        "albumin": 3.1,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history"
      ],
      "submission_date": "2023-05-05",
      "submission_day_of_week": "Friday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0049",
      "patient_demographics": {
        "age": 26,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 768,
        "crp": 7.7,
        "esr": 38,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "adverse_event"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-05-10",
      "submission_day_of_week": "Wednesday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0050",
      "patient_demographics": {
        "age": 27,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 351,
        "crp": 65.2,
        "esr": 37,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2023-05-16",
      "submission_day_of_week": "Tuesday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0051",
      "patient_demographics": {
        "age": 33,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1442,
        "crp": 35.1,
        "esr": 78,
        "albumin": 4.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 14,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-05-22",
      "submission_day_of_week": "Monday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0052",
      "patient_demographics": {
        "age": 31,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 377,
        "hbi_score": 17,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 33.6,
        "esr": 85,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "partial_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "disease_severity_scores",
        "physician_attestation",
        "medication_history"
      ],
      "submission_date": "2023-05-24",
      "submission_day_of_week": "Wednesday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0053",
      "patient_demographics": {
        "age": 51,
        "gender": "Male",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 316,
        "hbi_score": 17,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 14.3,
        "esr": 64,
        "albumin": 3.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "current_endoscopy",
        "colonoscopy_report"
      ],
      "submission_date": "2023-05-26",
      "submission_day_of_week": "Friday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Prior authorization form incomplete",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Prior authorization form incomplete"
    },
    {
      "case_id": "HC-2023-0054",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 555,
        "hbi_score": 14,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 57.5,
        "esr": 66,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 41,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-05-30",
      "submission_day_of_week": "Tuesday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0055",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 419,
        "hbi_score": 11,
        "ses_cd_score": 7,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 763,
        "crp": 13.6,
        "esr": 40,
        "albumin": 3.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 41,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-06-06",
      "submission_day_of_week": "Tuesday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0056",
      "patient_demographics": {
        "age": 41,
        "gender": "Male",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 347,
        "hbi_score": 8,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 952,
        "crp": 29.4,
        "esr": 59,
        "albumin": 3.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2023-06-06",
      "submission_day_of_week": "Tuesday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2023-0057",
      "patient_demographics": {
        "age": 65,
        "gender": "Female",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1301,
        "crp": 49.5,
        "esr": 78,
        "albumin": 3.0,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-06-10",
      "submission_day_of_week": "Saturday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0058",
      "patient_demographics": {
        "age": 59,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 308,
        "hbi_score": 11,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1446,
        "crp": 42.7,
        "esr": null,
        "albumin": 4.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 441
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "partial_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 144
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 324
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-06-15",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2023-0059",
      "patient_demographics": {
        "age": 54,
        "gender": "Female",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1181,
        "crp": 39.8,
        "esr": null,
        "albumin": 3.9,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 7,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 2,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2023-06-20",
      "submission_day_of_week": "Tuesday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Disease severity scores required"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0060",
      "patient_demographics": {
        "age": 45,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 364,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 406,
        "crp": 73.8,
        "esr": 52,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 290
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-06-21",
      "submission_day_of_week": "Wednesday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2023-0061",
      "patient_demographics": {
        "age": 36,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 555,
        "hbi_score": 14,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1196,
        "crp": 58.3,
        "esr": 28,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 19,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 326
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 26,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 50
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-06-26",
      "submission_day_of_week": "Monday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 6,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0062",
      "patient_demographics": {
        "age": 46,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1007,
        "crp": 34.0,
        "esr": null,
        "albumin": 3.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-06-28",
      "submission_day_of_week": "Wednesday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0063",
      "patient_demographics": {
        "age": 40,
        "gender": "Male",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 567,
        "hbi_score": 11,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 968,
        "crp": 77.6,
        "esr": 46,
        "albumin": 4.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 8,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 97
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 261
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 5,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-06-29",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0064",
      "patient_demographics": {
        "age": 31,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1148,
        "crp": 60.0,
        "esr": null,
        "albumin": 3.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 19,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history"
      ],
      "submission_date": "2023-07-07",
      "submission_day_of_week": "Friday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0065",
      "patient_demographics": {
        "age": 20,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 230,
        "hbi_score": 13,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 372,
        "crp": 49.0,
        "esr": 41,
        "albumin": 3.8,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-07-14",
      "submission_day_of_week": "Friday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0066",
      "patient_demographics": {
        "age": 40,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1490,
        "crp": 19.9,
        "esr": 61,
        "albumin": 3.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-07-17",
      "submission_day_of_week": "Monday",
      "submission_month": 7,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0067",
      "patient_demographics": {
        "age": 43,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 463,
        "hbi_score": 8,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 590,
        "crp": 35.5,
        "esr": 75,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 47,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "medication_history",
        "physician_attestation"
      ],
      "submission_date": "2023-07-21",
      "submission_day_of_week": "Friday",
      "submission_month": 7,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0068",
      "patient_demographics": {
        "age": 38,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 290,
        "hbi_score": null,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 16.7,
        "esr": null,
        "albumin": 2.9,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 28,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history"
      ],
      "submission_date": "2023-07-24",
      "submission_day_of_week": "Monday",
      "submission_month": 7,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Fecal calprotectin test results needed",
        "Prior treatment documentation needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0069",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 583,
        "hbi_score": 10,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 540,
        "crp": 41.2,
        "esr": 44,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 6,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 10,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy",
        "tb_screening"
      ],
      "submission_date": "2023-07-24",
      "submission_day_of_week": "Monday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0070",
      "patient_demographics": {
        "age": 42,
        "gender": "Female",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 487,
        "hbi_score": 19,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 928,
        "crp": 56.8,
        "esr": null,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "adverse_event"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_180_days",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report",
        "tb_screening",
        "fecal_calprotectin"
      ],
      "submission_date": "2023-07-25",
      "submission_day_of_week": "Tuesday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2023-0071",
      "patient_demographics": {
        "age": 22,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 239,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1340,
        "crp": 21.2,
        "esr": 73,
        "albumin": 3.8,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "partial_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 138
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 18,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-07-25",
      "submission_day_of_week": "Tuesday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0072",
      "patient_demographics": {
        "age": 47,
        "gender": "Male",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 594,
        "crp": 72.2,
        "esr": 50,
        "albumin": 3.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 2,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 437
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-07-25",
      "submission_day_of_week": "Tuesday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0073",
      "patient_demographics": {
        "age": 26,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1380,
        "crp": 62.8,
        "esr": null,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 354
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-07-26",
      "submission_day_of_week": "Wednesday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0074",
      "patient_demographics": {
        "age": 66,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 14.2,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 20,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2023-07-28",
      "submission_day_of_week": "Friday",
      "submission_month": 7,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 24,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 17
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0075",
      "patient_demographics": {
        "age": 60,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.913",
        "description": "Crohn's disease, unspecified, with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 377,
        "hbi_score": 12,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1155,
        "crp": 31.7,
        "esr": 68,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-07-29",
      "submission_day_of_week": "Saturday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2023-0076",
      "patient_demographics": {
        "age": 22,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 44.4,
        "esr": 66,
        "albumin": 3.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-08-12",
      "submission_day_of_week": "Saturday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0077",
      "patient_demographics": {
        "age": 31,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 224,
        "hbi_score": null,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 657,
        "crp": 58.7,
        "esr": 46,
        "albumin": 2.9,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-08-17",
      "submission_day_of_week": "Thursday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0078",
      "patient_demographics": {
        "age": 32,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 504,
        "hbi_score": 11,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1373,
        "crp": 41.2,
        "esr": 29,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 20,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 14,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "current_endoscopy",
        "colonoscopy_report"
      ],
      "submission_date": "2023-08-19",
      "submission_day_of_week": "Saturday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0079",
      "patient_demographics": {
        "age": 49,
        "gender": "Male",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 233,
        "hbi_score": 17,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 767,
        "crp": 41.8,
        "esr": 34,
        "albumin": 2.9,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 45,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-08-23",
      "submission_day_of_week": "Wednesday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0080",
      "patient_demographics": {
        "age": 40,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 498,
        "hbi_score": 14,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 654,
        "crp": 38.7,
        "esr": 20,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 6,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation",
        "current_endoscopy"
      ],
      "submission_date": "2023-08-24",
      "submission_day_of_week": "Thursday",
      "submission_month": 8,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 23,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 13
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0081",
      "patient_demographics": {
        "age": 62,
        "gender": "Male",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 315,
        "hbi_score": 18,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1143,
        "crp": 20.1,
        "esr": 32,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2023-08-24",
      "submission_day_of_week": "Thursday",
      "submission_month": 8,
      "outcome": "info_request",
      "days_to_decision": 6,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0082",
      "patient_demographics": {
        "age": 18,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 892,
        "crp": 54.8,
        "esr": null,
        "albumin": 4.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 232
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-08-25",
      "submission_day_of_week": "Friday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0083",
      "patient_demographics": {
        "age": 32,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 409,
        "hbi_score": 19,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 709,
        "crp": 42.1,
        "esr": 66,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 328
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2023-08-25",
      "submission_day_of_week": "Friday",
      "submission_month": 8,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0084",
      "patient_demographics": {
        "age": 30,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 280,
        "crp": 70.5,
        "esr": null,
        "albumin": 2.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "endoscopy_within_180_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-08-25",
      "submission_day_of_week": "Friday",
      "submission_month": 8,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 20,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 17
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0085",
      "patient_demographics": {
        "age": 35,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 300,
        "hbi_score": null,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 40.2,
        "esr": null,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 6,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prescription",
        "endoscopy_within_180_days",
        "diagnosis_documentation",
        "prior_auth_form",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-08-26",
      "submission_day_of_week": "Saturday",
      "submission_month": 8,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 5,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 11
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0086",
      "patient_demographics": {
        "age": 30,
        "gender": "Male",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 502,
        "hbi_score": 8,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1106,
        "crp": 32.2,
        "esr": 44,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "mtx_polyglutamate": 114
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-09-04",
      "submission_day_of_week": "Monday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0087",
      "patient_demographics": {
        "age": 56,
        "gender": "Female",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1361,
        "crp": 24.5,
        "esr": 51,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 20,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-09-06",
      "submission_day_of_week": "Wednesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0088",
      "patient_demographics": {
        "age": 43,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 462,
        "crp": 34.1,
        "esr": 76,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2023-09-10",
      "submission_day_of_week": "Sunday",
      "submission_month": 9,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 9,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 14
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0089",
      "patient_demographics": {
        "age": 51,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 429,
        "hbi_score": 17,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 778,
        "crp": 26.1,
        "esr": 64,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 416
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2023-09-12",
      "submission_day_of_week": "Tuesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0090",
      "patient_demographics": {
        "age": 58,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 338,
        "hbi_score": 20,
        "ses_cd_score": 9,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 866,
        "crp": 62.7,
        "esr": null,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 205
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-09-14",
      "submission_day_of_week": "Thursday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2023-0091",
      "patient_demographics": {
        "age": 48,
        "gender": "Female",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 511,
        "crp": 28.4,
        "esr": 61,
        "albumin": 4.0,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 237
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-09-16",
      "submission_day_of_week": "Saturday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0092",
      "patient_demographics": {
        "age": 44,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 255,
        "crp": 63.8,
        "esr": 25,
        "albumin": 4.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 12,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 219
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-09-17",
      "submission_day_of_week": "Sunday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0093",
      "patient_demographics": {
        "age": 30,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 499,
        "hbi_score": 8,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 282,
        "crp": 23.0,
        "esr": null,
        "albumin": 3.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 2,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-09-18",
      "submission_day_of_week": "Monday",
      "submission_month": 9,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 7,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 18
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0094",
      "patient_demographics": {
        "age": 39,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 291,
        "hbi_score": 17,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1477,
        "crp": 33.8,
        "esr": 49,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 51,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 286
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 227
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2023-09-19",
      "submission_day_of_week": "Tuesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0095",
      "patient_demographics": {
        "age": 67,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 78.9,
        "esr": 45,
        "albumin": 4.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-09-22",
      "submission_day_of_week": "Friday",
      "submission_month": 9,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 12,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 11
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0096",
      "patient_demographics": {
        "age": 44,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 501,
        "hbi_score": 20,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 47.6,
        "esr": null,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 18,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 28,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prescription",
        "endoscopy_within_180_days",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-09-24",
      "submission_day_of_week": "Sunday",
      "submission_month": 9,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 5,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 15
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0097",
      "patient_demographics": {
        "age": 45,
        "gender": "Male",
        "state": "GA"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 461,
        "crp": 7.1,
        "esr": 28,
        "albumin": 3.3,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 21,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation",
        "tb_screening"
      ],
      "submission_date": "2023-09-29",
      "submission_day_of_week": "Friday",
      "submission_month": 9,
      "outcome": "denied",
      "days_to_decision": 19,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0098",
      "patient_demographics": {
        "age": 43,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 903,
        "crp": 64.3,
        "esr": null,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-09-29",
      "submission_day_of_week": "Friday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0099",
      "patient_demographics": {
        "age": 22,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 526,
        "hbi_score": 16,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1357,
        "crp": 46.0,
        "esr": 22,
        "albumin": 4.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history"
      ],
      "submission_date": "2023-10-03",
      "submission_day_of_week": "Tuesday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0100",
      "patient_demographics": {
        "age": 40,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 423,
        "crp": 30.4,
        "esr": 69,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report"
      ],
      "submission_date": "2023-10-10",
      "submission_day_of_week": "Tuesday",
      "submission_month": 10,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0101",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 225,
        "hbi_score": 17,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 562,
        "crp": 47.5,
        "esr": 26,
        "albumin": 4.1,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-10-16",
      "submission_day_of_week": "Monday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2023-0102",
      "patient_demographics": {
        "age": 25,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 523,
        "hbi_score": 15,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 854,
        "crp": 73.8,
        "esr": 78,
        "albumin": 4.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2023-10-16",
      "submission_day_of_week": "Monday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0103",
      "patient_demographics": {
        "age": 20,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 799,
        "crp": 56.8,
        "esr": 70,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history"
      ],
      "submission_date": "2023-10-17",
      "submission_day_of_week": "Tuesday",
      "submission_month": 10,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Inadequate step therapy documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 6,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 11
      },
      "notes": "Denied: Inadequate step therapy documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0104",
      "patient_demographics": {
        "age": 27,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 365,
        "hbi_score": null,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 468,
        "crp": 22.8,
        "esr": 56,
        "albumin": 3.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [],
      "submission_date": "2023-10-21",
      "submission_day_of_week": "Saturday",
      "submission_month": 10,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 17,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 19
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0105",
      "patient_demographics": {
        "age": 54,
        "gender": "Female",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 597,
        "hbi_score": 19,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 53.3,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 15,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prescription",
        "endoscopy_within_180_days",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-11-02",
      "submission_day_of_week": "Thursday",
      "submission_month": 11,
      "outcome": "denied",
      "days_to_decision": 18,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 28,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 25
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2023-0106",
      "patient_demographics": {
        "age": 26,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 516,
        "hbi_score": 14,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 643,
        "crp": 7.1,
        "esr": 39,
        "albumin": 3.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 431
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 266
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-11-05",
      "submission_day_of_week": "Sunday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0107",
      "patient_demographics": {
        "age": 23,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 427,
        "hbi_score": 9,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 507,
        "crp": 18.3,
        "esr": 55,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "current_endoscopy",
        "medication_history"
      ],
      "submission_date": "2023-11-10",
      "submission_day_of_week": "Friday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2023-0108",
      "patient_demographics": {
        "age": 41,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 418,
        "hbi_score": 20,
        "ses_cd_score": 8,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 43.5,
        "esr": null,
        "albumin": 3.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2023-11-10",
      "submission_day_of_week": "Friday",
      "submission_month": 11,
      "outcome": "denied",
      "days_to_decision": 19,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 22,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 13
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0109",
      "patient_demographics": {
        "age": 37,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 359,
        "hbi_score": null,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 51.1,
        "esr": 63,
        "albumin": 2.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 4,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history"
      ],
      "submission_date": "2023-11-13",
      "submission_day_of_week": "Monday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Step therapy exception granted based on physician attestation of disease severity and clinical urgency. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0110",
      "patient_demographics": {
        "age": 35,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 2.4,
        "esr": null,
        "albumin": 2.8,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 2,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation"
      ],
      "documentation_missing": [
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2023-11-18",
      "submission_day_of_week": "Saturday",
      "submission_month": 11,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 7,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 24
      },
      "notes": "Denied: Inadequate step therapy documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2023-0111",
      "patient_demographics": {
        "age": 38,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 284,
        "hbi_score": 13,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 906,
        "crp": 59.1,
        "esr": 54,
        "albumin": 4.1,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 239
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "mtx_polyglutamate": 102
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-11-25",
      "submission_day_of_week": "Saturday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0112",
      "patient_demographics": {
        "age": 39,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 72.4,
        "esr": null,
        "albumin": 3.0,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 21,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2023-11-27",
      "submission_day_of_week": "Monday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2023-0113",
      "patient_demographics": {
        "age": 30,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 547,
        "hbi_score": 20,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 936,
        "crp": 51.2,
        "esr": 81,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 396
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-12-02",
      "submission_day_of_week": "Saturday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0114",
      "patient_demographics": {
        "age": 46,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1224,
        "crp": 47.2,
        "esr": null,
        "albumin": 2.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-12-03",
      "submission_day_of_week": "Sunday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2023-0115",
      "patient_demographics": {
        "age": 46,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1126,
        "crp": 60.2,
        "esr": null,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2023-12-15",
      "submission_day_of_week": "Friday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2023-0116",
      "patient_demographics": {
        "age": 69,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 320,
        "hbi_score": 20,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 598,
        "crp": 74.4,
        "esr": 27,
        "albumin": 2.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 8,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 10,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-12-15",
      "submission_day_of_week": "Friday",
      "submission_month": 12,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2023-0117",
      "patient_demographics": {
        "age": 50,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1071,
        "crp": 28.6,
        "esr": 64,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 37,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2023-12-17",
      "submission_day_of_week": "Sunday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Step therapy exception granted based on physician attestation of disease severity and clinical urgency. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2023-0118",
      "patient_demographics": {
        "age": 41,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 283,
        "hbi_score": 9,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 50.1,
        "esr": null,
        "albumin": 3.5,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history"
      ],
      "submission_date": "2023-12-27",
      "submission_day_of_week": "Wednesday",
      "submission_month": 12,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Inadequate step therapy documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Inadequate step therapy documentation"
    },
    {
      "case_id": "HC-2023-0119",
      "patient_demographics": {
        "age": 32,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 417,
        "hbi_score": 18,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1329,
        "crp": 78.3,
        "esr": 76,
        "albumin": 3.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "mtx_polyglutamate": 126
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 52,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 435
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2023-12-27",
      "submission_day_of_week": "Wednesday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2023-0120",
      "patient_demographics": {
        "age": 37,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1030,
        "crp": 15.9,
        "esr": 32,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "intolerance"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2023-12-31",
      "submission_day_of_week": "Sunday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0121",
      "patient_demographics": {
        "age": 19,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 744,
        "crp": 59.0,
        "esr": 68,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "partial_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-01-08",
      "submission_day_of_week": "Monday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0122",
      "patient_demographics": {
        "age": 33,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 181,
        "hbi_score": 11,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 4.4,
        "esr": 37,
        "albumin": 4.4,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 13,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2024-01-17",
      "submission_day_of_week": "Wednesday",
      "submission_month": 1,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 8,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 15
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2024-0123",
      "patient_demographics": {
        "age": 29,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 384,
        "crp": 44.9,
        "esr": null,
        "albumin": 4.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 37,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 7,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "intolerance"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-01-23",
      "submission_day_of_week": "Tuesday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0124",
      "patient_demographics": {
        "age": 55,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 347,
        "hbi_score": 18,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1478,
        "crp": 38.2,
        "esr": 40,
        "albumin": 3.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 261
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-01-24",
      "submission_day_of_week": "Wednesday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0125",
      "patient_demographics": {
        "age": 23,
        "gender": "Male",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 354,
        "hbi_score": 8,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 490,
        "crp": 61.0,
        "esr": 78,
        "albumin": 3.0,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 25,
          "outcome": "partial_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 80
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 297
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 291
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-01-26",
      "submission_day_of_week": "Friday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0126",
      "patient_demographics": {
        "age": 18,
        "gender": "Male",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 362,
        "hbi_score": null,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 42.5,
        "esr": 71,
        "albumin": 3.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 18,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 14,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-01-27",
      "submission_day_of_week": "Saturday",
      "submission_month": 1,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 21,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 25
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2024-0127",
      "patient_demographics": {
        "age": 23,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 358,
        "hbi_score": 10,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1150,
        "crp": 24.8,
        "esr": 57,
        "albumin": 3.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 375
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 21,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "mtx_polyglutamate": 122
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-01-27",
      "submission_day_of_week": "Saturday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0128",
      "patient_demographics": {
        "age": 31,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 397,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 730,
        "crp": 40.8,
        "esr": 26,
        "albumin": 2.5,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 20,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "mtx_polyglutamate": 147
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-01-28",
      "submission_day_of_week": "Sunday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0129",
      "patient_demographics": {
        "age": 64,
        "gender": "Male",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 40.0,
        "esr": 25,
        "albumin": 3.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2024-01-31",
      "submission_day_of_week": "Wednesday",
      "submission_month": 1,
      "outcome": "denied",
      "days_to_decision": 19,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2024-0130",
      "patient_demographics": {
        "age": 27,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 351,
        "hbi_score": 13,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 730,
        "crp": 12.5,
        "esr": 77,
        "albumin": 2.9,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 368
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 243
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-02-02",
      "submission_day_of_week": "Friday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 19,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0131",
      "patient_demographics": {
        "age": 45,
        "gender": "Female",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 25.6,
        "esr": 39,
        "albumin": 3.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 18,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-02-03",
      "submission_day_of_week": "Saturday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 24,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 17
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0132",
      "patient_demographics": {
        "age": 39,
        "gender": "Female",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 998,
        "crp": 31.1,
        "esr": 58,
        "albumin": 3.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 51,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2024-02-06",
      "submission_day_of_week": "Tuesday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2024-0133",
      "patient_demographics": {
        "age": 47,
        "gender": "Male",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 356,
        "hbi_score": 9,
        "ses_cd_score": 7,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 751,
        "crp": 71.2,
        "esr": null,
        "albumin": 3.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-02-20",
      "submission_day_of_week": "Tuesday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0134",
      "patient_demographics": {
        "age": 31,
        "gender": "Male",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 359,
        "hbi_score": 9,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 25.2,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 47,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "colonoscopy_report"
      ],
      "submission_date": "2024-02-21",
      "submission_day_of_week": "Wednesday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Inadequate step therapy documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Inadequate step therapy documentation"
    },
    {
      "case_id": "HC-2024-0135",
      "patient_demographics": {
        "age": 48,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 416,
        "hbi_score": 11,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 37.3,
        "esr": 61,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 25,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 147
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 308
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2024-02-29",
      "submission_day_of_week": "Thursday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0136",
      "patient_demographics": {
        "age": 32,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 287,
        "hbi_score": 18,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1474,
        "crp": 31.8,
        "esr": 26,
        "albumin": 2.9,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 18,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-03-03",
      "submission_day_of_week": "Sunday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0137",
      "patient_demographics": {
        "age": 56,
        "gender": "Female",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 532,
        "hbi_score": 9,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1389,
        "crp": 34.8,
        "esr": 37,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 51,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2024-03-09",
      "submission_day_of_week": "Saturday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2024-0138",
      "patient_demographics": {
        "age": 31,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 293,
        "hbi_score": null,
        "ses_cd_score": 12,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 573,
        "crp": 50.8,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "partial_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 149
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 237
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-03-12",
      "submission_day_of_week": "Tuesday",
      "submission_month": 3,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0139",
      "patient_demographics": {
        "age": 39,
        "gender": "Female",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 596,
        "hbi_score": null,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 737,
        "crp": 14.9,
        "esr": null,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 301
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-03-19",
      "submission_day_of_week": "Tuesday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0140",
      "patient_demographics": {
        "age": 31,
        "gender": "Female",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 338,
        "hbi_score": 9,
        "ses_cd_score": 12,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 643,
        "crp": 72.2,
        "esr": null,
        "albumin": 3.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 208
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-03-20",
      "submission_day_of_week": "Wednesday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0141",
      "patient_demographics": {
        "age": 52,
        "gender": "Female",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 648,
        "crp": 32.8,
        "esr": 59,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history"
      ],
      "submission_date": "2024-03-24",
      "submission_day_of_week": "Sunday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2024-0142",
      "patient_demographics": {
        "age": 33,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 674,
        "crp": 26.2,
        "esr": 62,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history"
      ],
      "submission_date": "2024-03-25",
      "submission_day_of_week": "Monday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0143",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 5.3,
        "esr": 70,
        "albumin": 2.7,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2024-03-28",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "denied",
      "days_to_decision": 18,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Inadequate step therapy documentation"
    },
    {
      "case_id": "HC-2024-0144",
      "patient_demographics": {
        "age": 50,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 292,
        "hbi_score": 18,
        "ses_cd_score": 25,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 18.2,
        "esr": 67,
        "albumin": 2.6,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 9,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-03-28",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 24,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 11
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0145",
      "patient_demographics": {
        "age": 29,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1371,
        "crp": 40.2,
        "esr": 44,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "intolerance"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 20,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2024-04-01",
      "submission_day_of_week": "Monday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2024-0146",
      "patient_demographics": {
        "age": 58,
        "gender": "Female",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1380,
        "crp": 9.0,
        "esr": 32,
        "albumin": 3.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 398
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-04-04",
      "submission_day_of_week": "Thursday",
      "submission_month": 4,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Dosing not consistent with guidelines",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 4,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 28
      },
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Denied: Dosing not consistent with guidelines Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2024-0147",
      "patient_demographics": {
        "age": 21,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 211,
        "hbi_score": 18,
        "ses_cd_score": 7,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 2.3,
        "esr": 57,
        "albumin": 4.1,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 18,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prescription",
        "endoscopy_within_180_days",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2024-04-04",
      "submission_day_of_week": "Thursday",
      "submission_month": 4,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 4,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 12
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0148",
      "patient_demographics": {
        "age": 64,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1362,
        "crp": 66.7,
        "esr": 72,
        "albumin": 4.0,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "partial_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 421
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-04-05",
      "submission_day_of_week": "Friday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0149",
      "patient_demographics": {
        "age": 21,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 233,
        "hbi_score": 10,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 440,
        "crp": 30.3,
        "esr": 77,
        "albumin": 3.5,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 427
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 225
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-04-06",
      "submission_day_of_week": "Saturday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0150",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 529,
        "hbi_score": 15,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 964,
        "crp": 57.5,
        "esr": 55,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 406
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-04-07",
      "submission_day_of_week": "Sunday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0151",
      "patient_demographics": {
        "age": 20,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 335,
        "hbi_score": 8,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1227,
        "crp": 27.5,
        "esr": 71,
        "albumin": 3.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 47,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 301
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-04-10",
      "submission_day_of_week": "Wednesday",
      "submission_month": 4,
      "outcome": "info_request",
      "days_to_decision": 4,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0152",
      "patient_demographics": {
        "age": 31,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 180,
        "hbi_score": null,
        "ses_cd_score": 25,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 2.4,
        "esr": 46,
        "albumin": 2.6,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "current_endoscopy",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2024-04-11",
      "submission_day_of_week": "Thursday",
      "submission_month": 4,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 22,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 26
      },
      "notes": "Denied: Step therapy requirement not met Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2024-0153",
      "patient_demographics": {
        "age": 45,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 531,
        "hbi_score": 15,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 41.2,
        "esr": 44,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-04-11",
      "submission_day_of_week": "Thursday",
      "submission_month": 4,
      "outcome": "info_request",
      "days_to_decision": 6,
      "info_request_details": [
        "Disease severity scores required",
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0154",
      "patient_demographics": {
        "age": 25,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 820,
        "crp": 55.2,
        "esr": null,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 400
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "intolerance"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-04-16",
      "submission_day_of_week": "Tuesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0155",
      "patient_demographics": {
        "age": 51,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 23.2,
        "esr": 78,
        "albumin": 4.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 26,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 423
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 20,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-05-02",
      "submission_day_of_week": "Thursday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0156",
      "patient_demographics": {
        "age": 44,
        "gender": "Female",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 590,
        "crp": 75.9,
        "esr": 65,
        "albumin": 2.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-05-08",
      "submission_day_of_week": "Wednesday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0157",
      "patient_demographics": {
        "age": 69,
        "gender": "Female",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 296,
        "hbi_score": 8,
        "ses_cd_score": 18,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1404,
        "crp": 32.2,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 52,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 321
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 390
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-05-16",
      "submission_day_of_week": "Thursday",
      "submission_month": 5,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0158",
      "patient_demographics": {
        "age": 31,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 39.1,
        "esr": 58,
        "albumin": 3.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "current_endoscopy",
        "colonoscopy_report",
        "fecal_calprotectin"
      ],
      "submission_date": "2024-05-19",
      "submission_day_of_week": "Sunday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0159",
      "patient_demographics": {
        "age": 44,
        "gender": "Male",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 578,
        "hbi_score": 13,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1239,
        "crp": 58.7,
        "esr": 37,
        "albumin": 3.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 5,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 4,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "current_endoscopy",
        "colonoscopy_report"
      ],
      "submission_date": "2024-05-21",
      "submission_day_of_week": "Tuesday",
      "submission_month": 5,
      "outcome": "info_request",
      "days_to_decision": 4,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0160",
      "patient_demographics": {
        "age": 64,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 233,
        "hbi_score": null,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 517,
        "crp": 19.9,
        "esr": 63,
        "albumin": 3.8,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-05-23",
      "submission_day_of_week": "Thursday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0161",
      "patient_demographics": {
        "age": 39,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 429,
        "hbi_score": 15,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 39.6,
        "esr": 21,
        "albumin": 4.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-05-27",
      "submission_day_of_week": "Monday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0162",
      "patient_demographics": {
        "age": 37,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 295,
        "hbi_score": 19,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1404,
        "crp": 8.1,
        "esr": 25,
        "albumin": 2.6,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 28,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-05-28",
      "submission_day_of_week": "Tuesday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0163",
      "patient_demographics": {
        "age": 37,
        "gender": "Male",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 282,
        "hbi_score": 19,
        "ses_cd_score": 25,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 917,
        "crp": 36.4,
        "esr": 77,
        "albumin": 3.2,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-05-29",
      "submission_day_of_week": "Wednesday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0164",
      "patient_demographics": {
        "age": 45,
        "gender": "Male",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 323,
        "hbi_score": 18,
        "ses_cd_score": 12,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 477,
        "crp": 57.2,
        "esr": null,
        "albumin": 3.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 41,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-05-30",
      "submission_day_of_week": "Thursday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0165",
      "patient_demographics": {
        "age": 53,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 347,
        "hbi_score": 16,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1284,
        "crp": 44.1,
        "esr": 45,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-06-06",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 23,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 20
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0166",
      "patient_demographics": {
        "age": 30,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 382,
        "hbi_score": null,
        "ses_cd_score": 12,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 20.8,
        "esr": 61,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-06-06",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0167",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 581,
        "hbi_score": null,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 79.4,
        "esr": 21,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-06-06",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2024-0168",
      "patient_demographics": {
        "age": 24,
        "gender": "Female",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 571,
        "hbi_score": 13,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 578,
        "crp": 57.4,
        "esr": 42,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 9,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 7,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-06-07",
      "submission_day_of_week": "Friday",
      "submission_month": 6,
      "outcome": "denied",
      "days_to_decision": 19,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0169",
      "patient_demographics": {
        "age": 40,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 746,
        "crp": 8.8,
        "esr": 34,
        "albumin": 3.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 397
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-06-09",
      "submission_day_of_week": "Sunday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0170",
      "patient_demographics": {
        "age": 24,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 302,
        "hbi_score": 20,
        "ses_cd_score": 25,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1408,
        "crp": 58.6,
        "esr": 62,
        "albumin": 3.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "disease_severity_scores",
        "physician_attestation",
        "medication_history"
      ],
      "submission_date": "2024-06-13",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0171",
      "patient_demographics": {
        "age": 24,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 497,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 20.5,
        "esr": 62,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 281
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2024-06-18",
      "submission_day_of_week": "Tuesday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0172",
      "patient_demographics": {
        "age": 40,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1200,
        "crp": 73.2,
        "esr": 46,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "fecal_calprotectin"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-06-20",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0173",
      "patient_demographics": {
        "age": 33,
        "gender": "Female",
        "state": "GA"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 508,
        "crp": 14.8,
        "esr": 21,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 313
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-06-21",
      "submission_day_of_week": "Friday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 6,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0174",
      "patient_demographics": {
        "age": 37,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 347,
        "hbi_score": null,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 807,
        "crp": 57.5,
        "esr": 40,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 13,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy",
        "tb_screening"
      ],
      "submission_date": "2024-06-22",
      "submission_day_of_week": "Saturday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2024-0175",
      "patient_demographics": {
        "age": 42,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 443,
        "hbi_score": null,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 658,
        "crp": 28.8,
        "esr": null,
        "albumin": 3.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2024-06-27",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0176",
      "patient_demographics": {
        "age": 22,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 570,
        "hbi_score": 17,
        "ses_cd_score": 25,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 319,
        "crp": 29.2,
        "esr": null,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 431
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-07-04",
      "submission_day_of_week": "Thursday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0177",
      "patient_demographics": {
        "age": 39,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 55.3,
        "esr": 41,
        "albumin": 3.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 28,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prescription",
        "endoscopy_within_180_days",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-07-05",
      "submission_day_of_week": "Friday",
      "submission_month": 7,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 19,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 11
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2024-0178",
      "patient_demographics": {
        "age": 22,
        "gender": "Female",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 436,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 910,
        "crp": 37.2,
        "esr": null,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 21,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "tb_screening",
        "fecal_calprotectin"
      ],
      "submission_date": "2024-07-10",
      "submission_day_of_week": "Wednesday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2024-0179",
      "patient_demographics": {
        "age": 66,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 475,
        "hbi_score": 14,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 50.4,
        "esr": 40,
        "albumin": 3.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2024-07-11",
      "submission_day_of_week": "Thursday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2024-0180",
      "patient_demographics": {
        "age": 29,
        "gender": "Male",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 287,
        "hbi_score": 15,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1124,
        "crp": 53.3,
        "esr": 37,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "intolerance",
          "tdm_documented": true,
          "mtx_polyglutamate": 90
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2024-07-14",
      "submission_day_of_week": "Sunday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2024-0181",
      "patient_demographics": {
        "age": 43,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 47.1,
        "esr": 38,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-07-17",
      "submission_day_of_week": "Wednesday",
      "submission_month": 7,
      "outcome": "denied",
      "days_to_decision": 12,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0182",
      "patient_demographics": {
        "age": 40,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 55.5,
        "esr": null,
        "albumin": 2.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 233
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2024-07-19",
      "submission_day_of_week": "Friday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0183",
      "patient_demographics": {
        "age": 68,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1434,
        "crp": 62.2,
        "esr": 65,
        "albumin": 2.9,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 350
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-07-22",
      "submission_day_of_week": "Monday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0184",
      "patient_demographics": {
        "age": 52,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 322,
        "hbi_score": 14,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 29.3,
        "esr": null,
        "albumin": 4.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 7,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "current_endoscopy",
        "colonoscopy_report"
      ],
      "submission_date": "2024-07-22",
      "submission_day_of_week": "Monday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0185",
      "patient_demographics": {
        "age": 25,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1033,
        "crp": 33.8,
        "esr": null,
        "albumin": 2.9,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 213
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-07-23",
      "submission_day_of_week": "Tuesday",
      "submission_month": 7,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0186",
      "patient_demographics": {
        "age": 67,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 574,
        "hbi_score": 17,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 533,
        "crp": 65.2,
        "esr": 35,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-07-24",
      "submission_day_of_week": "Wednesday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0187",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 256,
        "hbi_score": 8,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1200,
        "crp": 50.8,
        "esr": 56,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-07-25",
      "submission_day_of_week": "Thursday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2024-0188",
      "patient_demographics": {
        "age": 18,
        "gender": "Male",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 273,
        "hbi_score": 12,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1169,
        "crp": 34.7,
        "esr": 58,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 20,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2024-07-27",
      "submission_day_of_week": "Saturday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Step therapy exception granted based on physician attestation of disease severity and clinical urgency. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2024-0189",
      "patient_demographics": {
        "age": 43,
        "gender": "Female",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 250,
        "hbi_score": 14,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 676,
        "crp": 66.0,
        "esr": 70,
        "albumin": 4.5,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history"
      ],
      "submission_date": "2024-08-01",
      "submission_day_of_week": "Thursday",
      "submission_month": 8,
      "outcome": "denied",
      "days_to_decision": 18,
      "info_request_details": null,
      "denial_reason": "Inadequate step therapy documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Inadequate step therapy documentation"
    },
    {
      "case_id": "HC-2024-0190",
      "patient_demographics": {
        "age": 64,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 670,
        "crp": 56.6,
        "esr": 43,
        "albumin": 2.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-08-03",
      "submission_day_of_week": "Saturday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0191",
      "patient_demographics": {
        "age": 41,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 961,
        "crp": 58.2,
        "esr": 38,
        "albumin": 4.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 52,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 403
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-08-07",
      "submission_day_of_week": "Wednesday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0192",
      "patient_demographics": {
        "age": 34,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 351,
        "hbi_score": 8,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 932,
        "crp": 65.3,
        "esr": 29,
        "albumin": 3.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "adverse_event"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-08-14",
      "submission_day_of_week": "Wednesday",
      "submission_month": 8,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Disease severity scores required"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0193",
      "patient_demographics": {
        "age": 56,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 496,
        "hbi_score": 18,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 60.2,
        "esr": 42,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 26,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 20,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history"
      ],
      "submission_date": "2024-08-18",
      "submission_day_of_week": "Sunday",
      "submission_month": 8,
      "outcome": "denied",
      "days_to_decision": 12,
      "info_request_details": null,
      "denial_reason": "Inadequate step therapy documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Inadequate step therapy documentation"
    },
    {
      "case_id": "HC-2024-0194",
      "patient_demographics": {
        "age": 47,
        "gender": "Male",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 416,
        "crp": 16.8,
        "esr": null,
        "albumin": 2.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 18,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 208
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-08-31",
      "submission_day_of_week": "Saturday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0195",
      "patient_demographics": {
        "age": 39,
        "gender": "Male",
        "state": "GA"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 396,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1376,
        "crp": 25.6,
        "esr": 62,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 299
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "mtx_polyglutamate": 136
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2024-09-09",
      "submission_day_of_week": "Monday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2024-0196",
      "patient_demographics": {
        "age": 26,
        "gender": "Female",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 288,
        "crp": 52.1,
        "esr": 31,
        "albumin": 3.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 41,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 439
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 51,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 439
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-09-10",
      "submission_day_of_week": "Tuesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0197",
      "patient_demographics": {
        "age": 39,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 304,
        "hbi_score": 15,
        "ses_cd_score": 8,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 767,
        "crp": 75.6,
        "esr": 72,
        "albumin": 2.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 395
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-09-11",
      "submission_day_of_week": "Wednesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0198",
      "patient_demographics": {
        "age": 48,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 5.5,
        "esr": 24,
        "albumin": 2.6,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2024-09-12",
      "submission_day_of_week": "Thursday",
      "submission_month": 9,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0199",
      "patient_demographics": {
        "age": 36,
        "gender": "Male",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 564,
        "hbi_score": 20,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 654,
        "crp": 71.1,
        "esr": null,
        "albumin": 3.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-09-15",
      "submission_day_of_week": "Sunday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0200",
      "patient_demographics": {
        "age": 22,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.913",
        "description": "Crohn's disease, unspecified, with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 372,
        "hbi_score": null,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 393,
        "crp": 19.2,
        "esr": 20,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 233
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "partial_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 145
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 20,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2024-09-15",
      "submission_day_of_week": "Sunday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0201",
      "patient_demographics": {
        "age": 44,
        "gender": "Female",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 239,
        "hbi_score": null,
        "ses_cd_score": 7,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 76.3,
        "esr": null,
        "albumin": 3.8,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-09-28",
      "submission_day_of_week": "Saturday",
      "submission_month": 9,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Disease severity scores required",
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0202",
      "patient_demographics": {
        "age": 48,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1142,
        "crp": 49.2,
        "esr": 45,
        "albumin": 4.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "current_endoscopy",
        "medication_history"
      ],
      "submission_date": "2024-10-03",
      "submission_day_of_week": "Thursday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0203",
      "patient_demographics": {
        "age": 61,
        "gender": "Male",
        "state": "GA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1318,
        "crp": 54.8,
        "esr": 69,
        "albumin": 4.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 4,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 5,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-10-04",
      "submission_day_of_week": "Friday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0204",
      "patient_demographics": {
        "age": 34,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 331,
        "hbi_score": 15,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 9.5,
        "esr": 43,
        "albumin": 2.5,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "adverse_event"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 52,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [],
      "submission_date": "2024-10-04",
      "submission_day_of_week": "Friday",
      "submission_month": 10,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0205",
      "patient_demographics": {
        "age": 31,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 247,
        "hbi_score": null,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 439,
        "crp": 38.3,
        "esr": null,
        "albumin": 3.5,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 45,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 398
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2024-10-06",
      "submission_day_of_week": "Sunday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2024-0206",
      "patient_demographics": {
        "age": 24,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 532,
        "hbi_score": null,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1282,
        "crp": 13.9,
        "esr": 45,
        "albumin": 4.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-10-12",
      "submission_day_of_week": "Saturday",
      "submission_month": 10,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0207",
      "patient_demographics": {
        "age": 19,
        "gender": "Female",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 443,
        "hbi_score": null,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1499,
        "crp": 46.4,
        "esr": 48,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 19,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2024-10-19",
      "submission_day_of_week": "Saturday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2024-0208",
      "patient_demographics": {
        "age": 52,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 358,
        "hbi_score": 13,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 71.5,
        "esr": null,
        "albumin": 4.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 3,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2024-10-25",
      "submission_day_of_week": "Friday",
      "submission_month": 10,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2024-0209",
      "patient_demographics": {
        "age": 30,
        "gender": "Female",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 943,
        "crp": 65.3,
        "esr": 24,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 37,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 293
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 20,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-10-31",
      "submission_day_of_week": "Thursday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0210",
      "patient_demographics": {
        "age": 34,
        "gender": "Female",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 334,
        "hbi_score": 11,
        "ses_cd_score": 7,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 606,
        "crp": 24.9,
        "esr": null,
        "albumin": 3.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 16,
          "outcome": "partial_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 107
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 20,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-11-03",
      "submission_day_of_week": "Sunday",
      "submission_month": 11,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0211",
      "patient_demographics": {
        "age": 59,
        "gender": "Female",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 458,
        "hbi_score": 9,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 67.1,
        "esr": 31,
        "albumin": 4.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2024-11-03",
      "submission_day_of_week": "Sunday",
      "submission_month": 11,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0212",
      "patient_demographics": {
        "age": 60,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 389,
        "hbi_score": 20,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1299,
        "crp": 79.2,
        "esr": 75,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 25,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history",
        "tb_screening",
        "fecal_calprotectin"
      ],
      "submission_date": "2024-11-05",
      "submission_day_of_week": "Tuesday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2024-0213",
      "patient_demographics": {
        "age": 38,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 498,
        "crp": 47.5,
        "esr": 42,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 394
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-11-06",
      "submission_day_of_week": "Wednesday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0214",
      "patient_demographics": {
        "age": 47,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 443,
        "hbi_score": 15,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 263,
        "crp": 34.7,
        "esr": null,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 2,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2024-11-08",
      "submission_day_of_week": "Friday",
      "submission_month": 11,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 7,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 21
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2024-0215",
      "patient_demographics": {
        "age": 18,
        "gender": "Female",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 485,
        "crp": 50.5,
        "esr": 53,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-11-09",
      "submission_day_of_week": "Saturday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2024-0216",
      "patient_demographics": {
        "age": 33,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 405,
        "hbi_score": 14,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 492,
        "crp": 45.1,
        "esr": 59,
        "albumin": 2.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 14,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-11-10",
      "submission_day_of_week": "Sunday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0217",
      "patient_demographics": {
        "age": 22,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 276,
        "hbi_score": null,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 573,
        "crp": 6.2,
        "esr": 20,
        "albumin": 2.5,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "mtx_polyglutamate": 103
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 236
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-11-18",
      "submission_day_of_week": "Monday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0218",
      "patient_demographics": {
        "age": 53,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1195,
        "crp": 18.6,
        "esr": null,
        "albumin": 3.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "adverse_event"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report"
      ],
      "submission_date": "2024-11-19",
      "submission_day_of_week": "Tuesday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2024-0219",
      "patient_demographics": {
        "age": 39,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1347,
        "crp": 21.1,
        "esr": null,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 45,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-11-19",
      "submission_day_of_week": "Tuesday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0220",
      "patient_demographics": {
        "age": 34,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 443,
        "hbi_score": null,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 46.7,
        "esr": 57,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 7,
          "outcome": "partial_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 88
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "current_endoscopy"
      ],
      "submission_date": "2024-12-03",
      "submission_day_of_week": "Tuesday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2024-0221",
      "patient_demographics": {
        "age": 40,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 388,
        "hbi_score": 8,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 384,
        "crp": 31.7,
        "esr": 44,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "intolerance",
          "tdm_documented": true,
          "mtx_polyglutamate": 92
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 37,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 352
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 343
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2024-12-04",
      "submission_day_of_week": "Wednesday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2024-0222",
      "patient_demographics": {
        "age": 28,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1205,
        "crp": 56.1,
        "esr": 38,
        "albumin": 3.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "adverse_event"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-12-04",
      "submission_day_of_week": "Wednesday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0223",
      "patient_demographics": {
        "age": 23,
        "gender": "Female",
        "state": "GA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 494,
        "crp": 60.7,
        "esr": 64,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 385
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 45,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 272
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-12-05",
      "submission_day_of_week": "Thursday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0224",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 288,
        "hbi_score": 18,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 28.8,
        "esr": null,
        "albumin": 3.7,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history"
      ],
      "submission_date": "2024-12-05",
      "submission_day_of_week": "Thursday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0225",
      "patient_demographics": {
        "age": 33,
        "gender": "Male",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 487,
        "hbi_score": 17,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1035,
        "crp": 36.7,
        "esr": 54,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 18,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 2,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2024-12-13",
      "submission_day_of_week": "Friday",
      "submission_month": 12,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 21,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 18
      },
      "notes": "Denied: Step therapy requirement not met Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2024-0226",
      "patient_demographics": {
        "age": 42,
        "gender": "Female",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 555,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 852,
        "crp": 32.8,
        "esr": null,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 377
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 323
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2024-12-13",
      "submission_day_of_week": "Friday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2024-0227",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1497,
        "crp": 74.7,
        "esr": 37,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2024-12-18",
      "submission_day_of_week": "Wednesday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2024-0228",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 912,
        "crp": 78.4,
        "esr": null,
        "albumin": 3.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "adverse_event"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "intolerance"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 18,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-12-19",
      "submission_day_of_week": "Thursday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2024-0229",
      "patient_demographics": {
        "age": 65,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1350,
        "crp": 14.9,
        "esr": 74,
        "albumin": 2.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 421
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-12-21",
      "submission_day_of_week": "Saturday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2024-0230",
      "patient_demographics": {
        "age": 20,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 561,
        "hbi_score": 12,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 976,
        "crp": 23.7,
        "esr": 44,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2024-12-22",
      "submission_day_of_week": "Sunday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2024-0231",
      "patient_demographics": {
        "age": 36,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 462,
        "hbi_score": 13,
        "ses_cd_score": 7,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 981,
        "crp": 64.1,
        "esr": 66,
        "albumin": 3.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 211
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2024-12-23",
      "submission_day_of_week": "Monday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0232",
      "patient_demographics": {
        "age": 34,
        "gender": "Male",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 238,
        "hbi_score": null,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 13.0,
        "esr": null,
        "albumin": 4.3,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2025-01-03",
      "submission_day_of_week": "Friday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0233",
      "patient_demographics": {
        "age": 32,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 217,
        "hbi_score": 13,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 5.0,
        "esr": 28,
        "albumin": 2.8,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 4,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_180_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history",
        "tb_screening"
      ],
      "submission_date": "2025-01-05",
      "submission_day_of_week": "Sunday",
      "submission_month": 1,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Inadequate step therapy documentation"
    },
    {
      "case_id": "HC-2025-0234",
      "patient_demographics": {
        "age": 62,
        "gender": "Female",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 980,
        "crp": 51.4,
        "esr": 28,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 400
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-01-06",
      "submission_day_of_week": "Monday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0235",
      "patient_demographics": {
        "age": 33,
        "gender": "Male",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 338,
        "hbi_score": null,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1398,
        "crp": 39.1,
        "esr": null,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 288
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 277
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2025-01-07",
      "submission_day_of_week": "Tuesday",
      "submission_month": 1,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0236",
      "patient_demographics": {
        "age": 50,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1476,
        "crp": 61.4,
        "esr": 75,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 7,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 21,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-01-09",
      "submission_day_of_week": "Thursday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0237",
      "patient_demographics": {
        "age": 42,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 482,
        "hbi_score": 13,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1087,
        "crp": 36.4,
        "esr": 49,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 221
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 267
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-01-14",
      "submission_day_of_week": "Tuesday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2025-0238",
      "patient_demographics": {
        "age": 23,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 6.2,
        "esr": 37,
        "albumin": 2.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 28,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_180_days",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-01-14",
      "submission_day_of_week": "Tuesday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0239",
      "patient_demographics": {
        "age": 34,
        "gender": "Male",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 472,
        "hbi_score": 16,
        "ses_cd_score": 25,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 715,
        "crp": 46.5,
        "esr": 72,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "mtx_polyglutamate": 80
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 301
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 48,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 358
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-01-26",
      "submission_day_of_week": "Sunday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0240",
      "patient_demographics": {
        "age": 19,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 410,
        "hbi_score": 11,
        "ses_cd_score": 18,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 23.5,
        "esr": 75,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2025-01-27",
      "submission_day_of_week": "Monday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2025-0241",
      "patient_demographics": {
        "age": 46,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 278,
        "hbi_score": 18,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1240,
        "crp": 39.9,
        "esr": 57,
        "albumin": 3.0,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 18,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-01-28",
      "submission_day_of_week": "Tuesday",
      "submission_month": 1,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0242",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 300,
        "hbi_score": 18,
        "ses_cd_score": 8,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 75.2,
        "esr": 74,
        "albumin": 3.5,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 4,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-02-03",
      "submission_day_of_week": "Monday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 18,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 25
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2025-0243",
      "patient_demographics": {
        "age": 20,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 437,
        "crp": 5.4,
        "esr": 43,
        "albumin": 4.0,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 8,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 206
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2025-02-07",
      "submission_day_of_week": "Friday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0244",
      "patient_demographics": {
        "age": 37,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 485,
        "hbi_score": null,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 560,
        "crp": 70.5,
        "esr": 56,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "adverse_event"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2025-02-07",
      "submission_day_of_week": "Friday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0245",
      "patient_demographics": {
        "age": 61,
        "gender": "Female",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 572,
        "crp": 61.6,
        "esr": null,
        "albumin": 2.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-02-09",
      "submission_day_of_week": "Sunday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0246",
      "patient_demographics": {
        "age": 55,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 529,
        "hbi_score": 9,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1097,
        "crp": 35.8,
        "esr": 54,
        "albumin": 3.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-02-12",
      "submission_day_of_week": "Wednesday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0247",
      "patient_demographics": {
        "age": 65,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 550,
        "hbi_score": 11,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 27.5,
        "esr": 63,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "disease_severity_scores",
        "physician_attestation",
        "medication_history",
        "tb_screening"
      ],
      "submission_date": "2025-02-15",
      "submission_day_of_week": "Saturday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2025-0248",
      "patient_demographics": {
        "age": 30,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1261,
        "crp": 13.7,
        "esr": null,
        "albumin": 3.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-02-16",
      "submission_day_of_week": "Sunday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0249",
      "patient_demographics": {
        "age": 52,
        "gender": "Male",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 352,
        "hbi_score": null,
        "ses_cd_score": 17,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 846,
        "crp": 60.1,
        "esr": 56,
        "albumin": 4.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 293
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-02-17",
      "submission_day_of_week": "Monday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0250",
      "patient_demographics": {
        "age": 38,
        "gender": "Female",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 337,
        "hbi_score": 12,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1109,
        "crp": 44.4,
        "esr": 36,
        "albumin": 2.9,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "fecal_calprotectin"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-02-17",
      "submission_day_of_week": "Monday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0251",
      "patient_demographics": {
        "age": 20,
        "gender": "Male",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 543,
        "crp": 28.7,
        "esr": 69,
        "albumin": 2.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 362
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2025-02-20",
      "submission_day_of_week": "Thursday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0252",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 526,
        "hbi_score": null,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 592,
        "crp": 77.9,
        "esr": 54,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 337
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2025-02-20",
      "submission_day_of_week": "Thursday",
      "submission_month": 2,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2025-0253",
      "patient_demographics": {
        "age": 20,
        "gender": "Male",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 157,
        "hbi_score": 11,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 6.5,
        "esr": 79,
        "albumin": 4.3,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2025-02-22",
      "submission_day_of_week": "Saturday",
      "submission_month": 2,
      "outcome": "denied",
      "days_to_decision": 18,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0254",
      "patient_demographics": {
        "age": 23,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 496,
        "hbi_score": 10,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 697,
        "crp": 51.0,
        "esr": null,
        "albumin": 3.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 19,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-06",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0255",
      "patient_demographics": {
        "age": 24,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 423,
        "hbi_score": 20,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1297,
        "crp": 19.0,
        "esr": null,
        "albumin": 2.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "fecal_calprotectin"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-03-07",
      "submission_day_of_week": "Friday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0256",
      "patient_demographics": {
        "age": 40,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 598,
        "crp": 55.5,
        "esr": null,
        "albumin": 2.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "intolerance"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-07",
      "submission_day_of_week": "Friday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0257",
      "patient_demographics": {
        "age": 24,
        "gender": "Male",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 309,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 540,
        "crp": 34.5,
        "esr": 30,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 322
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "adverse_event"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "partial_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 99
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-11",
      "submission_day_of_week": "Tuesday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0258",
      "patient_demographics": {
        "age": 25,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 464,
        "hbi_score": 18,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 531,
        "crp": 38.1,
        "esr": 77,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2025-03-14",
      "submission_day_of_week": "Friday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0259",
      "patient_demographics": {
        "age": 24,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 263,
        "hbi_score": null,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 467,
        "crp": 37.5,
        "esr": null,
        "albumin": 3.3,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 324
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-15",
      "submission_day_of_week": "Saturday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0260",
      "patient_demographics": {
        "age": 29,
        "gender": "Male",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 320,
        "crp": 51.1,
        "esr": 61,
        "albumin": 3.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 222
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 426
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-19",
      "submission_day_of_week": "Wednesday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0261",
      "patient_demographics": {
        "age": 37,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 342,
        "hbi_score": 8,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 476,
        "crp": 22.2,
        "esr": null,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 325
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 141
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2025-03-20",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2025-0262",
      "patient_demographics": {
        "age": 31,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 283,
        "hbi_score": 10,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1254,
        "crp": 75.8,
        "esr": null,
        "albumin": 3.1,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "partial_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 68
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-20",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0263",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1400,
        "crp": 57.0,
        "esr": 70,
        "albumin": 3.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 37,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-21",
      "submission_day_of_week": "Friday",
      "submission_month": 3,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0264",
      "patient_demographics": {
        "age": 22,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 39.7,
        "esr": 79,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 7,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 5,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "current_endoscopy",
        "colonoscopy_report",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-03-22",
      "submission_day_of_week": "Saturday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0265",
      "patient_demographics": {
        "age": 41,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 517,
        "hbi_score": 9,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 351,
        "crp": 44.0,
        "esr": 77,
        "albumin": 2.4,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 421
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "mtx_polyglutamate": 51
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-23",
      "submission_day_of_week": "Sunday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2025-0266",
      "patient_demographics": {
        "age": 33,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 542,
        "hbi_score": null,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 41.7,
        "esr": 50,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "partial_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 17,
          "outcome": "inadequate_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "colonoscopy_report"
      ],
      "submission_date": "2025-03-27",
      "submission_day_of_week": "Thursday",
      "submission_month": 3,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Fecal calprotectin test results needed",
        "Prior treatment documentation needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0267",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 435,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1062,
        "crp": 54.4,
        "esr": 43,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 19,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 316
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-28",
      "submission_day_of_week": "Friday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2025-0268",
      "patient_demographics": {
        "age": 29,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 270,
        "hbi_score": 8,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1101,
        "crp": 74.0,
        "esr": null,
        "albumin": 4.2,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 41,
          "outcome": "intolerance"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-03-29",
      "submission_day_of_week": "Saturday",
      "submission_month": 3,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0269",
      "patient_demographics": {
        "age": 34,
        "gender": "Male",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 65.2,
        "esr": 31,
        "albumin": 3.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "partial_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 18,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-03-30",
      "submission_day_of_week": "Sunday",
      "submission_month": 3,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 14,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 27
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0270",
      "patient_demographics": {
        "age": 50,
        "gender": "Male",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 936,
        "crp": 68.3,
        "esr": 27,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-04-02",
      "submission_day_of_week": "Wednesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0271",
      "patient_demographics": {
        "age": 59,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 542,
        "hbi_score": 10,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 620,
        "crp": 27.0,
        "esr": 67,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 9,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2025-04-07",
      "submission_day_of_week": "Monday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0272",
      "patient_demographics": {
        "age": 40,
        "gender": "Female",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 388,
        "hbi_score": 13,
        "ses_cd_score": 18,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1066,
        "crp": 14.8,
        "esr": 55,
        "albumin": 2.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 27,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-04-11",
      "submission_day_of_week": "Friday",
      "submission_month": 4,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0273",
      "patient_demographics": {
        "age": 68,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 65.9,
        "esr": 66,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 3,
          "outcome": "partial_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 4,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-04-12",
      "submission_day_of_week": "Saturday",
      "submission_month": 4,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 13,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 25
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0274",
      "patient_demographics": {
        "age": 37,
        "gender": "Female",
        "state": "IL"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 268,
        "hbi_score": 16,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 432,
        "crp": 78.1,
        "esr": null,
        "albumin": 3.9,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 442
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2025-04-20",
      "submission_day_of_week": "Sunday",
      "submission_month": 4,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0275",
      "patient_demographics": {
        "age": 30,
        "gender": "Female",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 160,
        "hbi_score": 13,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 7.8,
        "esr": 52,
        "albumin": 3.8,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 2,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 2,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2025-04-21",
      "submission_day_of_week": "Monday",
      "submission_month": 4,
      "outcome": "denied",
      "days_to_decision": 12,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 18,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 11
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2025-0276",
      "patient_demographics": {
        "age": 32,
        "gender": "Male",
        "state": "TN"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 444,
        "hbi_score": 11,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1066,
        "crp": 23.2,
        "esr": 69,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 37,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 415
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 64
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2025-04-23",
      "submission_day_of_week": "Wednesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0277",
      "patient_demographics": {
        "age": 38,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 46.5,
        "esr": 58,
        "albumin": 3.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 7,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 15,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-04-23",
      "submission_day_of_week": "Wednesday",
      "submission_month": 4,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Disease severity scores required"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0278",
      "patient_demographics": {
        "age": 44,
        "gender": "Male",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 554,
        "hbi_score": 20,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1446,
        "crp": 42.4,
        "esr": 48,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "intolerance",
          "tdm_documented": true,
          "mtx_polyglutamate": 68
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 382
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 331
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-04-23",
      "submission_day_of_week": "Wednesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0279",
      "patient_demographics": {
        "age": 67,
        "gender": "Male",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1005,
        "crp": 39.1,
        "esr": 57,
        "albumin": 2.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 25,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 411
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-04-28",
      "submission_day_of_week": "Monday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0280",
      "patient_demographics": {
        "age": 20,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 592,
        "hbi_score": 13,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 47.9,
        "esr": null,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 3,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-04-29",
      "submission_day_of_week": "Tuesday",
      "submission_month": 4,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0281",
      "patient_demographics": {
        "age": 69,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1405,
        "crp": 13.4,
        "esr": 77,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 21,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report"
      ],
      "submission_date": "2025-05-01",
      "submission_day_of_week": "Thursday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0282",
      "patient_demographics": {
        "age": 51,
        "gender": "Male",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 459,
        "hbi_score": 16,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 34.7,
        "esr": 80,
        "albumin": 4.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 28,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2025-05-02",
      "submission_day_of_week": "Friday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0283",
      "patient_demographics": {
        "age": 69,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1028,
        "crp": 16.1,
        "esr": 22,
        "albumin": 3.6,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_180_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history"
      ],
      "submission_date": "2025-05-03",
      "submission_day_of_week": "Saturday",
      "submission_month": 5,
      "outcome": "info_request",
      "days_to_decision": 6,
      "info_request_details": [
        "Prior treatment documentation needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0284",
      "patient_demographics": {
        "age": 36,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 575,
        "crp": 9.9,
        "esr": 45,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 13,
          "outcome": "intolerance"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "partial_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-05-03",
      "submission_day_of_week": "Saturday",
      "submission_month": 5,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0285",
      "patient_demographics": {
        "age": 24,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.913",
        "description": "Crohn's disease, unspecified, with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 415,
        "hbi_score": 17,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1134,
        "crp": 20.3,
        "esr": 28,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 15,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 28,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2025-05-03",
      "submission_day_of_week": "Saturday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0286",
      "patient_demographics": {
        "age": 43,
        "gender": "Female",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 551,
        "hbi_score": 11,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 349,
        "crp": 8.8,
        "esr": 76,
        "albumin": 4.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 30,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_180_days",
        "step_therapy_exception_request",
        "urgency_documentation",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-05-06",
      "submission_day_of_week": "Tuesday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Step therapy exception granted based on physician attestation of disease severity and clinical urgency. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0287",
      "patient_demographics": {
        "age": 57,
        "gender": "Female",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 12.5,
        "esr": 54,
        "albumin": 4.3,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "intolerance"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 5,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-05-08",
      "submission_day_of_week": "Thursday",
      "submission_month": 5,
      "outcome": "info_request",
      "days_to_decision": 4,
      "info_request_details": [
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0288",
      "patient_demographics": {
        "age": 45,
        "gender": "Male",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.011",
        "description": "Crohn's disease of small intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 484,
        "hbi_score": 8,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1319,
        "crp": 36.6,
        "esr": 64,
        "albumin": 3.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 350
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "partial_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 67
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-05-09",
      "submission_day_of_week": "Friday",
      "submission_month": 5,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0289",
      "patient_demographics": {
        "age": 23,
        "gender": "Male",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.111",
        "description": "Crohn's disease of large intestine with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 429,
        "hbi_score": 9,
        "ses_cd_score": 24,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 562,
        "crp": 36.9,
        "esr": 52,
        "albumin": 4.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation"
      ],
      "documentation_missing": [
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "colonoscopy_report",
        "tb_screening"
      ],
      "submission_date": "2025-05-11",
      "submission_day_of_week": "Sunday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2025-0290",
      "patient_demographics": {
        "age": 18,
        "gender": "Female",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 61.1,
        "esr": 48,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 2,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-05-13",
      "submission_day_of_week": "Tuesday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 3,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 13
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0291",
      "patient_demographics": {
        "age": 19,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 448,
        "hbi_score": 17,
        "ses_cd_score": 8,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1476,
        "crp": 27.7,
        "esr": 64,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 25,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 3,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 25,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 2,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-05-17",
      "submission_day_of_week": "Saturday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0292",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 539,
        "crp": 26.8,
        "esr": 71,
        "albumin": 3.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-05-18",
      "submission_day_of_week": "Sunday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0293",
      "patient_demographics": {
        "age": 64,
        "gender": "Male",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 321,
        "hbi_score": 13,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1005,
        "crp": 24.2,
        "esr": 20,
        "albumin": 3.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 37,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2025-05-18",
      "submission_day_of_week": "Sunday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Medical necessity not established",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Denied: Medical necessity not established"
    },
    {
      "case_id": "HC-2025-0294",
      "patient_demographics": {
        "age": 46,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.913",
        "description": "Crohn's disease, unspecified, with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 300,
        "hbi_score": 8,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 51.7,
        "esr": 57,
        "albumin": 2.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2025-05-25",
      "submission_day_of_week": "Sunday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2025-0295",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 269,
        "crp": 42.5,
        "esr": 42,
        "albumin": 3.2,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 350
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-05-28",
      "submission_day_of_week": "Wednesday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Endoscopy report not current",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 15,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 24
      },
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Denied: Endoscopy report not current Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2025-0296",
      "patient_demographics": {
        "age": 25,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 22.0,
        "esr": 39,
        "albumin": 2.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 4,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-05-29",
      "submission_day_of_week": "Thursday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 10,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 28
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0297",
      "patient_demographics": {
        "age": 29,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 278,
        "hbi_score": 16,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 32.6,
        "esr": 62,
        "albumin": 4.2,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 4,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 14,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2025-05-29",
      "submission_day_of_week": "Thursday",
      "submission_month": 5,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2025-0298",
      "patient_demographics": {
        "age": 28,
        "gender": "Female",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.90",
        "description": "Ulcerative colitis, unspecified, without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 731,
        "crp": 55.5,
        "esr": null,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 23,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2025-05-30",
      "submission_day_of_week": "Friday",
      "submission_month": 5,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0299",
      "patient_demographics": {
        "age": 45,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 259,
        "hbi_score": null,
        "ses_cd_score": 15,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 536,
        "crp": 71.8,
        "esr": null,
        "albumin": 4.0,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 52,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 124
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 432
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 16,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-06-12",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0300",
      "patient_demographics": {
        "age": 19,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 418,
        "hbi_score": 9,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 24.7,
        "esr": 48,
        "albumin": 4.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "prior_treatment_records",
        "colonoscopy_report",
        "medication_history"
      ],
      "submission_date": "2025-06-13",
      "submission_day_of_week": "Friday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 4,
      "info_request_details": [
        "Prior treatment documentation needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0301",
      "patient_demographics": {
        "age": 30,
        "gender": "Female",
        "state": "WA"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 340,
        "hbi_score": 20,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 531,
        "crp": 44.7,
        "esr": 61,
        "albumin": 3.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "partial_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "mtx_polyglutamate": 65
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2025-06-16",
      "submission_day_of_week": "Monday",
      "submission_month": 6,
      "outcome": "approved",
      "days_to_decision": 9,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0302",
      "patient_demographics": {
        "age": 44,
        "gender": "Male",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 66.6,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 31,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "current_endoscopy",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-06-19",
      "submission_day_of_week": "Thursday",
      "submission_month": 6,
      "outcome": "denied",
      "days_to_decision": 15,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0303",
      "patient_demographics": {
        "age": 48,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 272,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 78.2,
        "esr": null,
        "albumin": 4.0,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 19,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "current_endoscopy",
        "colonoscopy_report"
      ],
      "submission_date": "2025-06-27",
      "submission_day_of_week": "Friday",
      "submission_month": 6,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0304",
      "patient_demographics": {
        "age": 18,
        "gender": "Female",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 354,
        "hbi_score": 8,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 917,
        "crp": 46.9,
        "esr": 71,
        "albumin": 2.9,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 15,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2025-07-10",
      "submission_day_of_week": "Thursday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0305",
      "patient_demographics": {
        "age": 31,
        "gender": "Female",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1413,
        "crp": 41.2,
        "esr": 57,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history"
      ],
      "submission_date": "2025-07-19",
      "submission_day_of_week": "Saturday",
      "submission_month": 7,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Inadequate step therapy documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Inadequate step therapy documentation"
    },
    {
      "case_id": "HC-2025-0306",
      "patient_demographics": {
        "age": 20,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 5,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 364,
        "crp": 38.3,
        "esr": 40,
        "albumin": 2.7,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 13,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2025-07-19",
      "submission_day_of_week": "Saturday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0307",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 373,
        "crp": 2.9,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "mild_to_moderate"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 36,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "medication_history",
        "tb_screening"
      ],
      "submission_date": "2025-07-24",
      "submission_day_of_week": "Thursday",
      "submission_month": 7,
      "outcome": "denied",
      "days_to_decision": 18,
      "info_request_details": null,
      "denial_reason": "Missing TB screening; disease severity does not meet criteria for expedited processing",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 30,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 26
      },
      "notes": "Denied: Inadequate step therapy documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2025-0308",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 382,
        "hbi_score": null,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1447,
        "crp": 13.2,
        "esr": null,
        "albumin": 3.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 28,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2025-07-27",
      "submission_day_of_week": "Sunday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0309",
      "patient_demographics": {
        "age": 21,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 304,
        "hbi_score": null,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1446,
        "crp": 59.7,
        "esr": 69,
        "albumin": 3.3,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 368
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 7,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2025-07-28",
      "submission_day_of_week": "Monday",
      "submission_month": 7,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity."
    },
    {
      "case_id": "HC-2025-0310",
      "patient_demographics": {
        "age": 42,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 26.7,
        "esr": null,
        "albumin": 3.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "partial_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-07-29",
      "submission_day_of_week": "Tuesday",
      "submission_month": 7,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Disease severity scores required",
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0311",
      "patient_demographics": {
        "age": 66,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 9.2,
        "esr": null,
        "albumin": 2.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 24,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-07-29",
      "submission_day_of_week": "Tuesday",
      "submission_month": 7,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0312",
      "patient_demographics": {
        "age": 26,
        "gender": "Female",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 371,
        "hbi_score": 16,
        "ses_cd_score": 22,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 50.9,
        "esr": 64,
        "albumin": 4.5,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_180_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-08-03",
      "submission_day_of_week": "Sunday",
      "submission_month": 8,
      "outcome": "info_request",
      "days_to_decision": 4,
      "info_request_details": [
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0313",
      "patient_demographics": {
        "age": 45,
        "gender": "Female",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Humira",
        "j_code": "J0135",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 48.0,
        "esr": 38,
        "albumin": 4.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [],
      "submission_date": "2025-08-18",
      "submission_day_of_week": "Monday",
      "submission_month": 8,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Prior conventional therapy not documented",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Prior conventional therapy not documented"
    },
    {
      "case_id": "HC-2025-0314",
      "patient_demographics": {
        "age": 41,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 600,
        "hbi_score": 12,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 925,
        "crp": 22.3,
        "esr": 35,
        "albumin": 3.5,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 33,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "mtx_polyglutamate": 147
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 243
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "intolerance"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 46,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 247
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-08-19",
      "submission_day_of_week": "Tuesday",
      "submission_month": 8,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0315",
      "patient_demographics": {
        "age": 42,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Cyltezo",
        "j_code": "Q5130",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 76.7,
        "esr": null,
        "albumin": 3.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 13,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 248
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-08-20",
      "submission_day_of_week": "Wednesday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0316",
      "patient_demographics": {
        "age": 52,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 545,
        "hbi_score": 10,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 910,
        "crp": 14.9,
        "esr": null,
        "albumin": 2.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 41,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 375
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 40,
          "outcome": "intolerance",
          "tdm_documented": true,
          "mtx_polyglutamate": 72
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 44,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 228
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-08-24",
      "submission_day_of_week": "Sunday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0317",
      "patient_demographics": {
        "age": 45,
        "gender": "Female",
        "state": "OH"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 40.0,
        "esr": 79,
        "albumin": 2.8,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 6,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 2,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_180_days",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-08-26",
      "submission_day_of_week": "Tuesday",
      "submission_month": 8,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2025-0318",
      "patient_demographics": {
        "age": 35,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K50.80",
        "description": "Crohn's disease of both small and large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 426,
        "hbi_score": 19,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1184,
        "crp": 31.0,
        "esr": 70,
        "albumin": 3.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 23,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2025-08-30",
      "submission_day_of_week": "Saturday",
      "submission_month": 8,
      "outcome": "denied",
      "days_to_decision": 12,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2025-0319",
      "patient_demographics": {
        "age": 42,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.913",
        "description": "Crohn's disease, unspecified, with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 334,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 42.7,
        "esr": null,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 11,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 5,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-09-02",
      "submission_day_of_week": "Tuesday",
      "submission_month": 9,
      "outcome": "info_request",
      "days_to_decision": 6,
      "info_request_details": [
        "Disease severity scores required",
        "Fecal calprotectin test results needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0320",
      "patient_demographics": {
        "age": 22,
        "gender": "Male",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 304,
        "hbi_score": 10,
        "ses_cd_score": 9,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 599,
        "crp": 55.9,
        "esr": 58,
        "albumin": 3.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 12,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 423
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-09-03",
      "submission_day_of_week": "Wednesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0321",
      "patient_demographics": {
        "age": 67,
        "gender": "Male",
        "state": "MD"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 310,
        "hbi_score": 10,
        "ses_cd_score": 8,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1063,
        "crp": 64.1,
        "esr": null,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 8,
          "outcome": "adverse_event"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 92
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2025-09-04",
      "submission_day_of_week": "Thursday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0322",
      "patient_demographics": {
        "age": 42,
        "gender": "Male",
        "state": "CA"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 347,
        "hbi_score": 17,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 425,
        "crp": 21.2,
        "esr": 50,
        "albumin": 4.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "laboratory_results",
        "tb_screening",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "prior_treatment_records",
        "disease_severity_scores",
        "physician_attestation",
        "medication_history"
      ],
      "submission_date": "2025-09-08",
      "submission_day_of_week": "Monday",
      "submission_month": 9,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 15,
      "appeal_outcome": "approved",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 26
      },
      "notes": "Denied: Missing disease severity documentation Successfully appealed with additional documentation."
    },
    {
      "case_id": "HC-2025-0323",
      "patient_demographics": {
        "age": 25,
        "gender": "Female",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 310,
        "crp": 72.2,
        "esr": 23,
        "albumin": 4.1,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "steroid_dependent",
          "tdm_documented": true,
          "6_tgn_level": 259
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "intolerance"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-09-09",
      "submission_day_of_week": "Tuesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0324",
      "patient_demographics": {
        "age": 30,
        "gender": "Female",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 301,
        "hbi_score": 20,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 36.2,
        "esr": 54,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 14,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 12,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_180_days",
        "imaging_with_fistula",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "laboratory_results",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-09-09",
      "submission_day_of_week": "Tuesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0325",
      "patient_demographics": {
        "age": 19,
        "gender": "Female",
        "state": "GA"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 435,
        "hbi_score": 8,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 607,
        "crp": 39.3,
        "esr": null,
        "albumin": 3.5,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 12,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2025-09-14",
      "submission_day_of_week": "Sunday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 6,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0326",
      "patient_demographics": {
        "age": 53,
        "gender": "Male",
        "state": "GA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 505,
        "hbi_score": 13,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 579,
        "crp": 34.2,
        "esr": 71,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 8,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 216
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "tb_screening",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-09-15",
      "submission_day_of_week": "Monday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0327",
      "patient_demographics": {
        "age": 28,
        "gender": "Female",
        "state": "MO"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 391,
        "hbi_score": null,
        "ses_cd_score": null,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 692,
        "crp": 17.2,
        "esr": 51,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 45,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 13,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2025-09-15",
      "submission_day_of_week": "Monday",
      "submission_month": 9,
      "outcome": "info_request",
      "days_to_decision": 4,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0328",
      "patient_demographics": {
        "age": 42,
        "gender": "Male",
        "state": "NY"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 417,
        "hbi_score": null,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 868,
        "crp": 25.5,
        "esr": 37,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "tb_screening"
      ],
      "submission_date": "2025-09-20",
      "submission_day_of_week": "Saturday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation. Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0329",
      "patient_demographics": {
        "age": 20,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.20",
        "description": "Ulcerative (chronic) proctitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 579,
        "crp": 58.4,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 21,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 260
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 9,
          "outcome": "adverse_event"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "current_endoscopy"
      ],
      "submission_date": "2025-09-22",
      "submission_day_of_week": "Monday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0330",
      "patient_demographics": {
        "age": 45,
        "gender": "Male",
        "state": "TX"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 773,
        "crp": 26.7,
        "esr": null,
        "albumin": 3.5,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 12,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 26,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-09-23",
      "submission_day_of_week": "Tuesday",
      "submission_month": 9,
      "outcome": "approved",
      "days_to_decision": 3,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0331",
      "patient_demographics": {
        "age": 25,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": 8,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 34.9,
        "esr": 37,
        "albumin": 3.5,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 8,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 38,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 346
        }
      ],
      "documentation_present": [
        "therapeutic_drug_monitoring",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "physician_attestation"
      ],
      "submission_date": "2025-09-28",
      "submission_day_of_week": "Sunday",
      "submission_month": 9,
      "outcome": "denied",
      "days_to_decision": 16,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "TDM results included for prior immunomodulator therapy. Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0332",
      "patient_demographics": {
        "age": 28,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.90",
        "description": "Crohn's disease, unspecified, without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 271,
        "hbi_score": 11,
        "ses_cd_score": 19,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 501,
        "crp": 22.5,
        "esr": 51,
        "albumin": 3.1,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 49,
          "outcome": "adverse_event",
          "tdm_documented": true,
          "6_tgn_level": 393
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 34,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 370
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [],
      "submission_date": "2025-10-03",
      "submission_day_of_week": "Friday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Step therapy exception granted based on physician attestation of disease severity and clinical urgency."
    },
    {
      "case_id": "HC-2025-0333",
      "patient_demographics": {
        "age": 48,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 9,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 918,
        "crp": 25.8,
        "esr": 53,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 20,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 18,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 39,
          "outcome": "partial_response",
          "tdm_documented": true,
          "6_tgn_level": 205
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-10-07",
      "submission_day_of_week": "Tuesday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2025-0334",
      "patient_demographics": {
        "age": 21,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.813",
        "description": "Crohn's disease of both small and large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 392,
        "hbi_score": 18,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 27.3,
        "esr": 66,
        "albumin": 2.7,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 7,
          "outcome": "adverse_event"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 6,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_90_days",
        "imaging_with_fistula",
        "step_therapy_exception_request",
        "urgency_documentation"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report",
        "fecal_calprotectin",
        "tb_screening"
      ],
      "submission_date": "2025-10-08",
      "submission_day_of_week": "Wednesday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Approved despite missing TB screening due to severe disease requiring urgent treatment. CRP and disease activity scores documented high severity. Step therapy exception granted based on physician attestation of disease severity and clinical urgency. Lab severity bundle (CRP>20, albumin<3.0, ESR>40) documented - approved under medical necessity."
    },
    {
      "case_id": "HC-2025-0335",
      "patient_demographics": {
        "age": 27,
        "gender": "Male",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 273,
        "hbi_score": null,
        "ses_cd_score": 14,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 51.3,
        "esr": 43,
        "albumin": 3.7,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 42,
          "outcome": "intolerance"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 3,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 7,
          "outcome": "partial_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 3,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2025-10-09",
      "submission_day_of_week": "Thursday",
      "submission_month": 10,
      "outcome": "denied",
      "days_to_decision": 17,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2025-0336",
      "patient_demographics": {
        "age": 24,
        "gender": "Female",
        "state": "NJ"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 6,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 28.0,
        "esr": 47,
        "albumin": 2.8,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "adverse_event"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 10,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "physician_attestation",
        "endoscopy_within_180_days",
        "colonoscopy_report"
      ],
      "documentation_missing": [
        "laboratory_results",
        "colonoscopy_report",
        "fecal_calprotectin"
      ],
      "submission_date": "2025-10-13",
      "submission_day_of_week": "Monday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 7,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0337",
      "patient_demographics": {
        "age": 31,
        "gender": "Male",
        "state": "IN"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "mayo_score": 8,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 578,
        "crp": 25.5,
        "esr": 29,
        "albumin": 4.2,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 22,
          "outcome": "adverse_event"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 21,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "physician_attestation"
      ],
      "documentation_missing": [
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "colonoscopy_report"
      ],
      "submission_date": "2025-10-26",
      "submission_day_of_week": "Sunday",
      "submission_month": 10,
      "outcome": "approved",
      "days_to_decision": 4,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fast-tracked due to comprehensive documentation."
    },
    {
      "case_id": "HC-2025-0338",
      "patient_demographics": {
        "age": 22,
        "gender": "Female",
        "state": "NC"
      },
      "diagnosis": {
        "primary_icd10": "K50.00",
        "description": "Crohn's disease of small intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hadlima",
        "j_code": "Q5119",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "cdai_score": 478,
        "hbi_score": 8,
        "ses_cd_score": 20,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 1159,
        "crp": 33.5,
        "esr": 50,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 52,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "mtx_polyglutamate": 88
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 18,
          "outcome": "loss_of_response",
          "tdm_documented": true,
          "6_tgn_level": 333
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-10-30",
      "submission_day_of_week": "Thursday",
      "submission_month": 10,
      "outcome": "info_request",
      "days_to_decision": 3,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0339",
      "patient_demographics": {
        "age": 37,
        "gender": "Male",
        "state": "AZ"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "cdai_score": 367,
        "hbi_score": 9,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 553,
        "crp": 48.2,
        "esr": 69,
        "albumin": 2.9,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 19,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 3,
          "outcome": "loss_of_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-11-01",
      "submission_day_of_week": "Saturday",
      "submission_month": 11,
      "outcome": "denied",
      "days_to_decision": 12,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2025-0340",
      "patient_demographics": {
        "age": 33,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "mayo_score": 10,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1383,
        "crp": 69.6,
        "esr": null,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 29,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 9,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 22,
          "outcome": "partial_response"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 16,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "prior_auth_form",
        "prescription",
        "diagnosis_documentation",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "disease_severity_scores",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-11-09",
      "submission_day_of_week": "Sunday",
      "submission_month": 11,
      "outcome": "denied",
      "days_to_decision": 18,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0341",
      "patient_demographics": {
        "age": 47,
        "gender": "Male",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K51.011",
        "description": "Ulcerative (chronic) pancolitis with rectal bleeding",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1321,
        "crp": 78.0,
        "esr": 46,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 43,
          "outcome": "intolerance",
          "tdm_documented": true,
          "6_tgn_level": 376
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 14,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-11-13",
      "submission_day_of_week": "Thursday",
      "submission_month": 11,
      "outcome": "info_request",
      "days_to_decision": 7,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0342",
      "patient_demographics": {
        "age": 18,
        "gender": "Male",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K50.10",
        "description": "Crohn's disease of large intestine without complications",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Remicade",
        "j_code": "J1745",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO"
      },
      "disease_severity": {
        "cdai_score": 297,
        "hbi_score": 13,
        "ses_cd_score": 23,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 837,
        "crp": 25.7,
        "esr": 80,
        "albumin": 3.9,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "adverse_event"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "inadequate_response",
          "tdm_documented": true,
          "6_tgn_level": 362
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-11-17",
      "submission_day_of_week": "Monday",
      "submission_month": 11,
      "outcome": "info_request",
      "days_to_decision": 4,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy."
    },
    {
      "case_id": "HC-2025-0343",
      "patient_demographics": {
        "age": 22,
        "gender": "Female",
        "state": "MA"
      },
      "diagnosis": {
        "primary_icd10": "K50.012",
        "description": "Crohn's disease of small intestine with intestinal obstruction",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 464,
        "hbi_score": 10,
        "ses_cd_score": 21,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 435,
        "crp": 59.2,
        "esr": null,
        "albumin": 4.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 20,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 13,
          "outcome": "partial_response"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 24,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-11-23",
      "submission_day_of_week": "Sunday",
      "submission_month": 11,
      "outcome": "approved",
      "days_to_decision": 10,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0344",
      "patient_demographics": {
        "age": 40,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.113",
        "description": "Crohn's disease of large intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 321,
        "hbi_score": null,
        "ses_cd_score": 16,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 27.3,
        "esr": 58,
        "albumin": 3.6,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 50,
          "outcome": "partial_response"
        },
        {
          "medication": "Sulfasalazine",
          "medication_class": "5-ASA",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 17,
          "outcome": "partial_response"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "endoscopy_within_180_days",
        "hepatitis_panel",
        "colonoscopy_report",
        "imaging_with_fistula"
      ],
      "documentation_missing": [
        "fecal_calprotectin"
      ],
      "submission_date": "2025-12-03",
      "submission_day_of_week": "Wednesday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 8,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Fecal calprotectin waived; endoscopy within 180 days documented active mucosal disease."
    },
    {
      "case_id": "HC-2025-0345",
      "patient_demographics": {
        "age": 65,
        "gender": "Male",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K51.00",
        "description": "Ulcerative (chronic) pancolitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Adalimumab",
        "brand": "Hyrimoz",
        "j_code": "Q5114",
        "mechanism": "TNF-alpha inhibitor",
        "route": "Subcutaneous",
        "dose": "40mg every 2 weeks",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "PPO"
      },
      "disease_severity": {
        "mayo_score": 12,
        "uceis_score": 6,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 1131,
        "crp": 43.9,
        "esr": 59,
        "albumin": 3.1,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "partial_response"
        },
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 26,
          "outcome": "intolerance"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-12-11",
      "submission_day_of_week": "Thursday",
      "submission_month": 12,
      "outcome": "info_request",
      "days_to_decision": 5,
      "info_request_details": [
        "Additional clinical documentation requested"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted."
    },
    {
      "case_id": "HC-2025-0346",
      "patient_demographics": {
        "age": 56,
        "gender": "Female",
        "state": "WI"
      },
      "diagnosis": {
        "primary_icd10": "K51.30",
        "description": "Ulcerative (chronic) rectosigmoiditis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Avsola",
        "j_code": "Q5121",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "mayo_score": 7,
        "uceis_score": 7,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": null,
        "crp": 46.9,
        "esr": null,
        "albumin": 4.4,
        "severity_classification": "moderate_to_severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 32,
          "outcome": "partial_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 12,
          "outcome": "adverse_event"
        }
      ],
      "documentation_present": [
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "medication_history",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [
        "laboratory_results",
        "disease_severity_scores",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-12-12",
      "submission_day_of_week": "Friday",
      "submission_month": 12,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Missing disease severity documentation",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 12,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 30
      },
      "notes": "Denied: Missing disease severity documentation"
    },
    {
      "case_id": "HC-2025-0347",
      "patient_demographics": {
        "age": 18,
        "gender": "Male",
        "state": "FL"
      },
      "diagnosis": {
        "primary_icd10": "K50.013",
        "description": "Crohn's disease of small intestine with fistula",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "HDHP"
      },
      "disease_severity": {
        "cdai_score": 308,
        "hbi_score": 8,
        "ses_cd_score": 11,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 17.0,
        "esr": null,
        "albumin": 2.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 4,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 35,
          "outcome": "loss_of_response"
        },
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "adverse_event"
        },
        {
          "medication": "Methotrexate",
          "medication_class": "Immunomodulator",
          "duration_weeks": 5,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days",
        "imaging_with_fistula"
      ],
      "documentation_missing": [],
      "submission_date": "2025-12-14",
      "submission_day_of_week": "Sunday",
      "submission_month": 12,
      "outcome": "denied",
      "days_to_decision": 13,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 21,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": true,
        "peer_to_peer_conducted": false,
        "days_to_appeal_decision": 22
      },
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2025-0348",
      "patient_demographics": {
        "age": 42,
        "gender": "Female",
        "state": "PA"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Renflexis",
        "j_code": "Q5104",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "UnitedHealthcare",
        "plan_type": "POS"
      },
      "disease_severity": {
        "cdai_score": 286,
        "hbi_score": 11,
        "ses_cd_score": 13,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": 253,
        "crp": 13.9,
        "esr": 70,
        "albumin": 2.7,
        "severity_classification": "moderate"
      },
      "prior_treatments": [
        {
          "medication": "6-Mercaptopurine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 8,
          "outcome": "inadequate_response"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 10,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-12-19",
      "submission_day_of_week": "Friday",
      "submission_month": 12,
      "outcome": "denied",
      "days_to_decision": 14,
      "info_request_details": null,
      "denial_reason": "Step therapy requirement not met",
      "appeal_filed": true,
      "appeal_filed_days_after_denial": 20,
      "appeal_outcome": "denied",
      "appeal_details": {
        "additional_documentation_submitted": false,
        "peer_to_peer_conducted": true,
        "days_to_appeal_decision": 20
      },
      "notes": "Denied: Step therapy requirement not met"
    },
    {
      "case_id": "HC-2025-0349",
      "patient_demographics": {
        "age": 18,
        "gender": "Female",
        "state": "MI"
      },
      "diagnosis": {
        "primary_icd10": "K50.911",
        "description": "Crohn's disease, unspecified, with rectal bleeding",
        "icd10_family": "K50",
        "condition_type": "crohns"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "HMO-POS"
      },
      "disease_severity": {
        "cdai_score": 488,
        "hbi_score": 15,
        "ses_cd_score": 10,
        "mayo_score": null,
        "uceis_score": null,
        "fecal_calprotectin": null,
        "crp": 59.9,
        "esr": 28,
        "albumin": 3.9,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 11,
          "outcome": "partial_response"
        },
        {
          "medication": "Azathioprine",
          "medication_class": "Immunomodulator",
          "duration_weeks": 15,
          "outcome": "steroid_dependent"
        }
      ],
      "documentation_present": [
        "prescription",
        "diagnosis_documentation",
        "prior_auth_form"
      ],
      "documentation_missing": [
        "fecal_calprotectin",
        "disease_severity_scores",
        "current_endoscopy",
        "prior_treatment_records",
        "laboratory_results",
        "medication_history",
        "physician_attestation",
        "colonoscopy_report"
      ],
      "submission_date": "2025-12-28",
      "submission_day_of_week": "Sunday",
      "submission_month": 12,
      "outcome": "info_request",
      "days_to_decision": 6,
      "info_request_details": [
        "Disease severity scores required",
        "Fecal calprotectin test results needed",
        "Prior treatment documentation needed"
      ],
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": null
    },
    {
      "case_id": "HC-2025-0350",
      "patient_demographics": {
        "age": 62,
        "gender": "Female",
        "state": "VA"
      },
      "diagnosis": {
        "primary_icd10": "K51.50",
        "description": "Left sided colitis without complications",
        "icd10_family": "K51",
        "condition_type": "uc"
      },
      "medication": {
        "name": "Infliximab",
        "brand": "Inflectra",
        "j_code": "Q5103",
        "mechanism": "TNF-alpha inhibitor",
        "route": "IV infusion",
        "dose": "5mg/kg",
        "step_therapy_position": 1
      },
      "payer": {
        "name": "Cigna",
        "plan_type": "EPO"
      },
      "disease_severity": {
        "mayo_score": 11,
        "uceis_score": null,
        "cdai_score": null,
        "hbi_score": null,
        "ses_cd_score": null,
        "fecal_calprotectin": 708,
        "crp": 48.3,
        "esr": null,
        "albumin": 4.0,
        "severity_classification": "severe"
      },
      "prior_treatments": [
        {
          "medication": "Budesonide",
          "medication_class": "Corticosteroid",
          "duration_weeks": 15,
          "outcome": "steroid_dependent"
        },
        {
          "medication": "Mesalamine",
          "medication_class": "5-ASA",
          "duration_weeks": 17,
          "outcome": "adverse_event"
        },
        {
          "medication": "Prednisone",
          "medication_class": "Corticosteroid",
          "duration_weeks": 6,
          "outcome": "inadequate_response"
        }
      ],
      "documentation_present": [
        "fecal_calprotectin",
        "therapeutic_drug_monitoring",
        "disease_severity_scores",
        "prior_auth_form",
        "prescription",
        "prior_treatment_records",
        "diagnosis_documentation",
        "laboratory_results",
        "medication_history",
        "crp_results",
        "tb_screening",
        "physician_attestation",
        "hepatitis_panel",
        "colonoscopy_report",
        "endoscopy_within_90_days"
      ],
      "documentation_missing": [],
      "submission_date": "2025-12-28",
      "submission_day_of_week": "Sunday",
      "submission_month": 12,
      "outcome": "approved",
      "days_to_decision": 5,
      "info_request_details": null,
      "denial_reason": null,
      "appeal_filed": false,
      "appeal_outcome": null,
      "appeal_details": null,
      "notes": "Complete documentation package submitted. TDM results included for prior immunomodulator therapy. Fast-tracked due to comprehensive documentation."
    }
  ]
}